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Untreated and symptomatic aortic stenosis (AS) is associated with high mortality.
Surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation 
(TAVI) are two treatment options for patients with severe AS. Patients receiving
SAVR and TAVI are often 80 years and older.
Delirium, an acute state of confusion characterized by temporary and fluctuating 
decline in attention and cognition, is common in older patients after cardiac surgery.
Yet, knowledge about octogenarians undergoing invasive cardiovascular therapy is 
scarce, and delirium after TAVI remains to be systematically explored.
Aims
The overall aim of this study was to investigate delirium in octogenarian patients 
undergoing SAVR or TAVI by determining its incidence, identifying risk factors,
describing its onset and time course, and by determining if delirium can be used to 
predict physical and cognitive function, self-reported health status, first-time hospital 
readmissions and mortality 1 and 6 months after aortic valve treatment.
Materials and Methods
This is a prospective cohort study of octogenarian patients with AS, scheduled for 
elective treatment with SAVR or TAVI at a tertiary university hospital in western 
Norway. Delirium was the main outcome of the study. Inclusion criteria were: age 80 
years-old and older and previous acceptance for treatment with SAVR or TAVI.
Exclusion criteria were: denied consent to participate in the study and inability to 
speak Norwegian. Between 2011 and 2013, 143 patients were included in the study.
Demographic and clinical information was collected from hospital information 
system registers, patients’ medical records or by interviewing included patients, as 
appropriate. Delirium was assessed for 5 postoperative days with the Confusion
Assessment Method. Activities of daily living, instrumental activities of daily living 
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and self-reported health status were measured with the Barthel Index, the Nottingham 
Extended Activities of Daily Living Scale (IADL) and The 12-Item Short Form 
Health Survey (SF-12), at baseline and at 1 and 6-month follow-up. Cognitive status 
was assessed at baseline and at 6-month follow-up with the Mini-Mental State 
Examination (MMSE).
Results
The mean age of included patients was 83.5 years (SD 2.7) and TAVI was performed 
in 46% of them. Patients undergoing SAVR had a higher incidence of delirium than
patients treated with TAVI (66% vs 44%, p = 0.01). Multivariate logistic regression 
analysis revealed that reduced cognitive function at baseline (p = 0.03) and treatment 
with SAVR (p = 0.02) are risk factors for delirium in octogenarian patients after aorta
valve treatment. No differences in the number of days with delirium were found 
between patient groups (p = 0.20) but the onset and course of delirium in patients 
treated with SAVR was more unpredictable (p = 0.003) than it was in patients treated 
with TAVI (Paper I).
Patients with and without delirium after SAVR had lower IADL function at 1-month 
follow-up (scores from 58 to 42 and from 58 to 50 respectively p 0.02). However,
this function returned to baseline levels after 6 months. Improvements in the Physical 
Component Summary score of SF-12 were found in patients not having delirium and 
treated with SAVR (from 39 to 48, p < 0.001). No differences between patient groups 
in other outcomes were identified. Regression models suggest that delirium after 
SAVR might predict IADL scores1-month after treatment (not significant, p-values
0.07) but does not predict large differences in ADL, cognitive function or SF-12 
scores in octogenarian AS patients. Patients experiencing delirium after TAVI had a 
lower ADL (from 19 to 16, p < 0.001) and IADL function (from 49 to 40, p = 0.003)
1 month after the procedure. In TAVI patients without delirium, the physical 
component score of SF-12 increased after 1 and 6 months (30 to 35, p = 0.04 and 30
to 35, p = 0.02 respectively). Regression analyses established that delirium following 
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TAVI predicted lower ADL and IADL function at 1 but not at 6-month follow-up
(Paper II).
First-time readmissions and death 1 and 6 months after SAVR or TAVI were more
common in octogenarian patients who experienced delirium. The effect of delirium 
was greatest during the first two months after discharge (adjusted hazard ratio 2.9 
(95% CI: 1.5 to 5.7).The most common discharge diagnosis at readmission was 
related to the circulatory system (Paper III).
Conclusions
Delirium is often present after aortic valve treatment, especially in patients receiving
SAVR. In addition to be a risk factor for delirium in octogenarian patients, SAVR 
was associated with a more unpredictable onset and course of delirium. Patients who 
experienced delirium, regardless treatment type, appear to have lower short-term 
IADL function. Yet, delirium does not seem to confer long-term reductions in 
physical, mental or self-reported health status in this patient group. Compared to 
patients without delirium, first-time readmissions and mortality were more common 6
months after hospital discharge in patients who had experienced delirium.
Our study provides additional evidence showing that delirium is a serious hospital 
complication that could be associated with negative outcomes such as lower physical 
function, morbidity and mortality 1 and 6 months after aortic valve treatment, also 
when more gentle techniques like TAVI are used. These findings are also relevant
when designing future studies and implementing strategies that could lead to the
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Delirium is a disorder characterized by an acute, reversible and fluctuating reduction 
of attention and cognition.1 Delirium can develop at any age2 but older hospitalized 
patients are especially vulnerable.1 Even though it has been described since
antiquity,3 delirium remains insufficiently identified and little understood,1,4 also in 
cardiac wards.
Cardiology has witnessed a paradigm change following increases in life expectancy,5
and technological advances have allowed the safe performance of cardiac surgery in
patients 80 years-old and older.6 7 In industrialized countries, aortic stenosis (AS) has
become an increasingly common valvular heart disease.8 9 The mortality rate of 
severe and untreated AS is high after symptoms of angina, syncope and heart failure 
appear.10 Great efforts have been made to improve survival in patients with severe 
AS, being surgical aortic valve replacement (SAVR) and transcatheter aortic valve 
implantation (TAVI) two invasive treatments for the condition.11-13 More often than
before, cardiology has come in contact with older patients to which outcomes of 
surgery in terms of physical function, cognitive status and quality of life are as
important as survival.5 Delirium is common after cardiac surgery,1 yet the majority of 
studies in this area have been done in patients younger than 80 years and they have 
combined several cardiac procedures.14-19 It remains to be established if delirium 
following the novel and less invasive TAVI has the same incidence and follows the 
same pattern as delirium after SAVR.
A clear understanding about differences (and/or similarities) in the incidence, risk 
factors, onset and course of delirium following SAVR and TAVI is needed. Increased
evidence has shown that the burden of delirium on patients, families and health care 
systems can be long lasting.20-23 Delirium after TAVI has not been systematically 
studied and the predictive value of delirium on physical and cognitive function, self-
reported health, readmissions and mortality following hospital discharge remains to 
be established. Increased knowledge about SAVR and TAVI, and their interaction 
with delirium might provide important clinical contributions that will eventually be 
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reflected on the wellbeing of patients and relatives, and in an increased quality of care 
from health care professionals.
1.1 Delirium
1.1.1 The concept of delirium
Before 1980, terms such as “sundown syndrome,” “acute confusion state,”
“postoperative psychosis” and “intensive care psychosis” were used to address
delirium.24 25 The concept of delirium remains somehow vague, but there is a 
consensus about it being a state of altered cerebral function that appears as a 
consequence of stressors26 or physical illness.27 A new era within the field of delirium 
started after a method to operationalize its diagnosis was published.28 Based on the 
third revised version of the Diagnostic and Statistical Manual of Mental Disorders 
(DMS), Inouye et al. comprised the clinical features of delirium to create the
Confusion Assessment Method (CAM).28 The CAM focuses on the four core features
of delirium; 1. acute onset and fluctuating course, 2. inattention, 3. disorganized 
thinking, and 4. altered level of consciousness. Delirium is diagnosed when feature 1 
and 2 are present, and either 3 or 4 are displayed.28 New and revised versions of the 
DMS have allowed a more inclusive and clinically safe interpretation of delirium.29
It can be difficult to differentiate delirium from other disorders such as dementia or 
depression. In general, delirium can be defined as a fluctuating state of confusion 
characterized by acute changes in cognition and disturbance of consciousness.30
Dementia, on the other hand, is a chronic and progressive neurodegenerative 
condition that leads to cognitive decline and that interferes with daily life.31 It is still 
uncertain whether delirium leads to dementia or vice versa, and studies elucidating
the relationship between the two conditions have been warranted.1 31 According to the 
World Health Organization, depression is a “disorder characterized by sadness, loss 
of interest or pleasure, feelings of guilt or self-worth, disturbed sleep or appetite, 
feelings of tiredness and poor concentration.”32 Patients with depression and delirium 
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can display apathy, extreme need for sleep and concentration problems. Table 1 
shows differences and similarities between delirium, dementia and depression.
Table 1: Comparison between features of delirium, dementia and depression.
Criteria Delirium Dementia Depression
Onset Acute within hours to 
days
Slow and progressive Progressive
Duration Reversible. Hours to 





From week to 
months
Attention Reduced ability to focus, 
sustain or shift attention
Generally intact until 
late in the progression 
of the disease
Reduced
Orientation Reduced Generally intact until 
later in the 
progression of the 
disease
Generally intact
Consciousness Fluctuating Generally intact until 
late in the progression 
of the disease
Generally intact




anomia or aphasia is 
possible
Normal to slow
Origin Underlying medical 
condition, substance 




Sleep Sleep disturbances Sleep disturbances Insomnia or 
hypersomnia
Activity Periods of high and low 
physical activity
Periods of high 
physical activity
In severe cases, 
lethargy
Adapted from Fong et al. (2015)31 and Downing et al. (2013)33
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1.1.2 Different manisfestations of delirium
The presentation of delirium is heterogeneous and this heterogeneity might 
complicate its identification. Based on psychomotor behavior, Lipowski (1980)34
classified delirium as hyperactive, hypoactive and mixed. Hyperactive delirium is
characterized by hallucinations, agitation, irritability and hypervigilance.30 33 This
presentation is probably easier to identify in a hospital setting as patients can become 
agitated, and because they are prone to pull out intravenous lines, cardiac monitoring 
equipment and/or urinary catheters. Patients with hypoactive delirium, on the other 
hand, can show signs of lethargy and little spontaneous movement.30 These patients 
are easily overseen as they can stay quietly in their beds and demand little attention 
from the staff.4 Nevertheless, it is common that patients with delirium experience a 
combination between the hypoactive and hyperactive form.
1.1.3 Epidemiology 
The prevalence of delirium in the general population has been estimated to be 0.7%.35
However, this prevalence increases with age, and could be as high as to 10% for 
community-dwelling individuals 85 years-old and older.36 In hospital settings, the 
highest incidence of delirium is found in intensive care units (19-85%), orthopedic
wards (12-51%) and in cardiac surgery departments (11-46%).1
1.1.4 Etiology of delirium
The scientific field of delirium is relatively new, and a clear understanding of why 
some patients become delirious is still unclear. It has been suggested that delirium 
can be understood as an “acute brain failure” that results as a response to one or 
several pathophysiological stressors.26 Predisposing and precipitating factors might 
propitiate the development of delirium.1 Predisposing factors refer to intrinsic 
individual characteristics that make some patients more vulnerable to develop
delirium.1 37Advanced age -old), cognitive and physical impairment, 
several comorbidities and previous history of stroke, are examples of predisposing 
risk factors for delirium.1 Precipitating factors also influence the development of 
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delirium, but they have the potential of being modifiable.37 Surgery, infections, use of 
physical restraints and sleep deprivation are examples of precipitating factors.1 When 
interacting, predisposing and precipitating factors can lead to delirium.1 37 An
undernourished individual with i.e. multiple comorbidities, polypharmacy and
dementia might be more vulnerable to develop delirium when facing a simple 
diagnosis such as a urinary tract infection. On the other hand, in a robust patient,
delirium will develop only when severe conditions are present.
1.1.5 Diagnosis
The diagnosis of delirium is mostly based on clinical observation of the features 
defined by the DSM or by the International Classification of Diseases, 10th edition 
(ICD-10)38. The CAM28 is perhaps the most used diagnostic tool for delirium,39 and
the instrument with best psychometric properties.40. A new version that can be 
applied on three minutes (3D-CAM) was recently published.41 More specialized
diagnostic instruments such as the Family-CAM,42 CAM-Intensive Care Unit43 and
the paediatric-CAM44 have emerged from the original CAM.
Other instruments used to evaluate the presence of delirium are; the Delirium 
Observation Screening Scale (DOSS)45, Delirium Rating Scale (DRS),46 and
NEECHAM Confusion Scale.47 A new but increasingly more used screening tool is
the 4 “A”s Test (4AT).48 This instrument provides a rapid initial assessment of four of 
the core features of delirium: alertness, age and orientation, attention and acute 
change or fluctuating course of cognition or other mental functions.48
Instruments used to diagnose delirium can be classified according to its 
administration form as “observational,” “interactive” or “mixed.”40 For observational 
instruments, the diagnosis is done by scrutinizing whether the features of delirium are
present. Interactive instruments rely on information gathered with an active
interaction between rater and the patient, while mixed instruments depend on both 
observational and interactive data. Table 2 presents an overview of the most widely 
known and validated instruments for the detection of delirium in older hospitalized 
















































































































































































































































































































































































1.1.6 Consequences of delirium after cardiac surgery
Delirium has been associated with several negative outcomes. Among hip fracture 
patients, delirium has been identified as a risk factor for institutionalization and 
functional decline,22 and as a predictor of dementia 6 months later49. Patients with 
delirium after cardiac surgery are more susceptible to in-hospital falls (p < 0.001),50
have a longer length of hospital stay (p < 0.001)50 51 and they more often require 
skilled assistance by the time of hospital discharge (p < 0.001).50 51 Additionally, 
hospital readmissions21 and increased risk of mortality51 52 are more often found in
patients having delirium after cardiac surgery.
For older patients, the opportunity to keep physical function and independence is 
perhaps as important as survival. Koster et al.21 studied a group of individuals after
cardiac surgery and found that mobility was significantly reduced in patients who 
experienced delirium.21 Rudolph and colleagues,17 reported important reductions in
IADL performance 1 month after cardiac surgery in patients who experienced 
delirium, although these differences were not significant at 6-month follow-up17. As 
frightening as loss of mobility and IADL function, is cognitive dysfunction. Several 
studies have reported an increased risk of cognitive problems the first month after 
cardiac surgery,53-55 even though cognitive function seems to return to baseline levels
by the time 6-month follow-up is performed.54 55
1.2 Aortic stenosis
AS is a narrowing of the aortic valve emerging as a consequence of progressive 
fibrosis and calcification.56 It is the most common form for valvular cardiac lesion in
individuals from industrialized countries57 58 and its prevalence increases with age.59
A meta-analysis of 9723 patients, age 75 years-old and older, established a
prevalence of AS of 12%. Of these patients, 3.4% had a diagnosis of severe AS.60
These numbers seem to support an important Norwegian study, not included in the 
mentioned meta-analysis, which reported a prevalence rate of AS of 3.9% in a cohort 
of patients between 70-79 years of age.59
24
1.2.1 Etiology and course of aortic stenosis
Anatomical, genetic and clinical factors lead to fibrosis and calcification of the aortic 
valve, and can eventually result in AS.61 Regarding anatomical factors, individuals 
born with a two leaflets aortic valve, rather than the normal trileaflet, are more likely 
to experience hemodynamic stress, calcification, rigidity and narrowing of the aortic 
orifice.58 Older age, hypertension and diabetes are clinical factors that have 
traditionally been associated with AS.62 In underdeveloped countries, rheumatic heart 
disease is still leading to an inflammation and fibrosis of the valve leaflets that might
create narrowing of the aortic valve.58 This narrowing causes stiffness, reduction in 
the valve area, increases in leaf ventricular afterload and work, and eventually death.
1.2.2 Classification
Based on symptoms, leaflet anatomy, valve hemodynamic and left ventricular 
function AS can be classified in four stages.61 63Table 3 shows the stages of the 




























































































































































































































































































































































































































































































































































































































































































































Once AS has been identified, patients should receive education, regular medical 
controls, treatment for other comorbidities and echocardiography on regular bases.62
63 Currently, no medical treatment is sufficient to address severe AS58 and without 
invasive treatment, live expectancy is reduced when symptoms in form of angina, 
syncope and heart failure, appear.8 10
SAVR is the standard approach in patients with a low to intermediate surgical risk.61
Even though age is not a contraindication to SAVR,58 before the introduction of 
TAVI, as many as 33% of patients 75 years-old and older were denied aortic valve 
surgery.64 SAVR is a highly invasive procedure, performed under general anaesthesia
and requiring sternotomy and cardiopulmonary bypass.65 Two types of artificial aortic 
valves are available in the market; bioprosthetic and mechanical and bioprosthetic,
being the first one the recommended option for patients 65 years-old and older.63 66
TAVI is a novel procedure, initially designed for high-risk patients, not able to 
undergo SAVR.13 Treatment with TAVI can be performed under local anaesthesia
and without sternotomy or cardiopulmonary bypass.65 Under TAVI, the diseased
aortic valve is replaced with a bioprosthetic valve inserted through a catheter.13 TAVI
is an alternative to patients when survival is expected to be at least 1 year after the 
procedure.62
28
2. Rationale for the study
Delirium and severe AS are associated with negative outcomes. Technical advances 
in the field of cardiology have allowed successful treatment for AS that can also be 
used in older patients with high surgical risk.13 As the oldest population continues to 
grow, it is expected that surgical procedures in this group will escalate.
There is a growing amount of knowledge related to delirium. Yet, research focusing 
on delirium in octogenarian patients following treatment for aortic stenosis is scarce. 
Even though older surgical patients are especially vulnerable to delirium,67
multicomponent interventions can reduce its occurrence.68 69
Delirium is a phenomenon that requires a multidisciplinary approach, and close 
contact with patients is decisive. Nurses have an especial role as they are among the 
health care professionals standing closer to the patient. They are also in close contact 
to patients’ relatives and are often the first receiving information about abrupt 
changes in arousal, attention and cognition. Physicians rely on nurses for information 
when assessing these changes, and when identifying the fluctuations that characterize 
delirium. Other health care professionals such as physiotherapist or laboratory 
personal might chose nurses to discuss what they perceive as deficits in attention or
disruption in mental function.
Delirium after treatment for AS in octogenarian patients brings together two
specialities within nursing; cardiology and geriatrics. A better understanding of the
incidence, potential risk factors, course and consequences of delirium after SAVR 
and TAVI might increase its identification, rise acknowledgment about cost
associated with its development systems and enable the design of multicomponent 




The overall objective of the study was to describe and understand delirium in 
octogenarian patients undergoing SAVR or TAVI by determining its incidence, 
identifying risk factors, describing its onset and time course, and by determining if
delirium can be used to predict physical and cognitive function, self-reported health
status, first-time readmission and mortality 1 and 6 months after aortic valve therapy.
More specifically, the aims of the study were:
To determine the incidence of postoperative delirium (PD) in octogenarian 
patients with AS requiring SAVR or TAVI, to identify risk factors for the 
development of delirium, and to describe possible differences in the onset and 
course of PD in octogenarians treated with SAVR or TAVI.
To determine how delirium could predict activities of daily living (ADL), 
instrumental activities of daily living (IADL), cognitive function, and self-
reported health status in octogenarian patients 1 and 6 months after treatment 
with SAVR or TAVI.
To determine if delirium can predict first-time readmissions and mortality in
octogenarians 1 and 6 months after SAVR and TAVI.
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4. Materials and methods
4.1 Design and setting
In order to address the aims of this study, an observational, prospective cohort study 
of octogenarian patients with severe and symptomatic AS undergoing elective SAVR 
or TAVI was conducted. This study was part of the “Delirium in octogenarians 
undergoing cardiac surgery or intervention – CARDELIR”. The main outcome of 
CARDELIR was the presence/absence of postoperative delirium. Patients were 
included at Haukeland University Hospital, a tertiary university hospital performing
all SAVR and TAVI procedures in western Norway.
4.2 Study population
Between February 2011 and August 2013, patients fulfilling the inclusion criteria 
were invited to participate in the study.
Inclusion criteria were:
Age 80 years and older
Previous acceptance for SAVR or TAVI
Exclusion criteria were:
Inability to speak and understand Norwegian
Declined consent to participate in the study
A heart team including cardiologists, thoracic surgeons and interventionists evaluated 
octogenarians with severe AS previously referred to our hospital, and identified those 
not suitable for SAVR. Severe AS was defined as follows: aortic valve area < 0.6
cm2/m2, mean gradient of > 40mmHg and maximum jet velocity > 4.0 m/s.70 Patients
disqualified for SAVR had previously received CABG or thoracic radiotherapy, had 
severe respiratory insufficiency, or other comorbidities that could compromise their
recovery.71
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During the inclusion period, 162 octogenarians were treated for AS with SAVR or
TAVI at our hospital. Eligibility criteria were fulfilled by 147 patients, and 144 of 
them agreed to participate. One of the included patients withdrew consent before 
surgery, and 7 additional patients were either not responsive or died within 5 days 
after treatment, leaving complete data for 136 patients.
4.3 Assessments
4.3.1 Registers (Paper I-III)
Hospital information system registers
The hospital surgery data base ORBIT was used to identify patients 80 years-old and 
older scheduled to receive treatment with SAVR or TAVI before arrival to the 
hospital. It was also used to gather information regarding cardiac operative mortality
risk (EuroSCORE)72 (Paper I).
The electronic patient record system helped to schedule 1 and 6-month follow-up
appointments and to identify patients who, in the meantime, had died (Paper II). The 
system also provided the information required to come in contact with patients unable 
to attend follow-up consultations (Paper II), and to identify first-time readmissions 
and mortality 1 and 6 months after discharge (Paper III).
Patients’ medical records
Electronic patient medical records provided baseline clinical characteristics and
information regarding the American Society of Anaesthesiologists (ASA) Physical 
Status Classification System.73 Patient medical records were also used to track reports 
about acute changes in attention, abnormal motoric activity, sleep disturbances, use of
postoperative medications and date of hospital discharge (Paper I and III).
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4.3.2 Delirium (Paper I-III)
Assessment of the main outcome (delirium), was performed with the Confusion 
Assessment Method (CAM).28A commonly used tool39 that has proven to be valid 
and reliable.28
4.3.3 Cognitive function (Paper I and II)
The Mini Mental State Examination
The Mini-Mental State Examination74 (MMSE) is a widely known cognitive test75
that evaluates orientation, registration, recall and naming, and which requires a short
amount of time to administer.74 The MMSE has proven to be a valid and reliable 
instrument to test global cognitive function.74
4.3.4 Physical function (Paper I and II)
Barthel Index (Paper I and II)
The Barthel Index assesses 10 basic self-care activities: bowel and bladder control, 
toilet use, feeding, grooming, transfer, mobility, dressing, use of stairs and bathing76.
Even though the initial scoring system of the Barthel Index ranged between 0–100, a 
modified version with scores from 0-2077 is often used.78 Higher scores in the index 
represent higher levels of independence.76 79 The psychometric properties of the 
Barthel Index have been shown in several studies.78 79
Nottingham Extended Activities of Daily Living Index (Paper II)
This index evaluates 22 complex activities of daily living, distributed within 4 major 
areas: mobility, kitchen, domestic and leisure activities.80 Scores are placed in a range 
between 0 and 66, with low scores representing worse levels of independence.81 The
index has shown sufficient psychometric properties to assess extended activities of 
daily living.80
Frailty (Paper I)
The Study of Osteoporotic Fractures (SOF) Frailty Index was used to evaluate
frailty.82 This index identifies individuals at risk of negative outcomes by using 3
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items: weight loss, inability to rise from a chair five times without using the arms as 
body support, and reduced energy level.83 Patients giving a positive answer to two or 
more of the items are considered to be frail.83 The SOF frailty index is a valid and 
reliable instrument.83 84
4.3.5 Assessment of health status (Paper II)
The Short-form 12-item Health Survey (SF-12) (Paper II)
The SF-12 was used to evaluate subjective general health.85 This instrument is based 
on 12 items that lead to two summary scores: A physical component summary (PCS) 
and a mental component summary (MCS). The highest score in each of the 
component summaries is 100, with high scores representing higher levels of 
perceived health.85 The SF-12 has proven to be a valid and reliable instrument.85






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Patients filling the inclusion criteria were approached by the time they arrived at the 
hospital, usually the day before surgery or intervention. Information about the
CARDELIR study was presented individually by a member of the research team.
Patients interested in joining the study signed a consent form. Information required 
for the Barthel index, the SOF-frailty index and the MMSE was collected at the time
of inclusion by interview and/or observation as appropriate. At the end of inclusion
procedure, patients received a set of self-administered questionnaires intended to 
evaluate IADL and subjective general health. These questionnaires were then
collected before SAVR or TAVI was performed. Demographic and clinical data were 
gathered from medical records or interview, as appropriate.
4.4.2 Assessment of delirium
Members of the research group trained in the use of CAM were responsible for 
assessing delirium. Nursing staff at the Section of Thoracic Surgery received regular
information about delirium and its features, and were encouraged to report symptoms 
of delirium at every shift. After surgery or intervention, included patients were 
approached and assessed for delirium daily, around noon, from postoperative day 1 to 
5, including weekends and holidays. Patients were assessed for inattention, 
disorganized thinking, and altered level of consciousness and disorientation. Medical, 
nursing and physiotherapist’ reports from the previous 24 hours were also considered 
when CAM was scored.
4.4.3 One- and six-month assessments
Follow-up visits were scheduled at the hospital 1 and 6 months after treatment. 
Information regarding ADL function, current living conditions (living at home, 
nursing home or at a rehabilitation unit) and hospital readmissions was collected by 
interviewing the patient at follow-up times. Data regarding hospital readmissions and
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length of hospital stay was also controlled with the electronic patient record system.
Self-report forms containing IADL and SF-12 questionnaires were provided to the 
patients. If a patient was unable to attend a follow-up visit and a new appointment 
could not be scheduled within a window of 2 weeks, telephone contact was 
attempted. Over the phone, information required to fill out the Barthel Index, to list
current living conditions and to register hospital readmissions was gathered. Self-
report forms containing IADL and SF-12 questionnaires were then mailed, together 
with an additional envelope addressed to CARDELIR investigators, to the patients for 
completion at home. Frailty and cognitive function was assessed after 6 months, but 
only for patients attending follow-up visits.
4.4.4 One- and six-month first-time readmission and mortality
Since patients in this study belong to five different regional hospitals (Helse Førde, 
Helse Fonna, Helse Stavanger, Haraldsplass Deaconess Hospital and Helse Bergen), 
especial approval from each of these institutions was gathered to access date of first-
time hospital readmission and discharge diagnosis. Close contact between the
principal investigation of the CARDELIR-study (TMN) and a person representing the 
electronic hospital systems was required to collect the information needed without 
threatening confidentiality.
4.5 Statistical data analysis
Data management and initial statistical analyses were performed with IBM SPSS for 
Windows, Version 21.0 (Paper I) and 22.0 (Paper II) and 23.0 (Paper III) (IBM
SPSS Statistics for Windows, Armonk, NY, USA). For other analyses, R 3.0.2.
(Paper I), R 3.1.1 (Paper II), R 3.2.3 (Paper III) (R Foundation for Statistical 
Computing, Vienna, Austria)86 were used. Power analyses (Paper I) was calculated 




Descriptive statistics of continuous variables were performed using means and
standard deviations (SD). Categorical variables were analyzed as absolute numbers 
and percentages (Paper I-III).
4.5.2 Comparisons
Group comparisons (Delirium/Non-delirium and SAVR/TAVI) were performed with 
chi-squared or Fisher’s exact tests for categorical variables, and Welch’s test (test not 
assuming equal variances) for continuous variables (Paper I-III).
4.5.3 Regressions
Univariate and multivariate logistic regression analysis were used to determine risk 
factors for delirium after aortic valve treatment (Paper I).
4.5.4 Longitudinal models
In Paper II, longitudinal linear models were fitted (separately) to estimate the mean 
ADL, IADL, MMSE, SF-12 Physical Component Summary, and SF-12 Mental 
Component Summary scores at baseline, 1- and 6-month follow-up. These
longitudinal linear models were fitted with time, delirium and the interaction between 
time and delirium as explanatory factors. For estimating how delirium could improve 
predictions over baseline scores alone or baseline scores and other risk/comorbidity 
factors, linear longitudinal models were fitted for the scores at 1- and 6-month 
follow-up, using the baseline score as an explanatory variable (for the unadjusted 
analysis), or the baseline score, gender, Charlson Comorbidity Index, and logistic 
EuroSCORE I as explanatory variables (for the adjusted analysis). All longitudinal 
models were fitted separately for each treatment (SAVR/TAVI), using generalized 
least squares with an unstructured correlation matrix.
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4.5.5 Sensitivity analysis
Sensitivity analyses were used in Paper II. As it was not possible to assume that data 
were missing completely at random (MCAR), a likelihood-based longitudinal model 
that required only the much weaker missing at random (MAR) assumption was used.
Since there could be informative censoring not captured by the model (for example, 
patients with greater improvements from baseline were more likely to respond to the 
follow-up questionnaire), sensitivity analysis for the changes from baseline were
performed. In these analyses, all missing data was replaced with the patients’ baseline 
values, and then the statistical analyses were repeated.
4.5.6 Survival models
Differences in the time to onset of delirium following SAVR and TAVI was explored 
using a logrank test for interval-censored data (Paper I).87 88 Kaplan–Meier curves 
and an exact Gehan–Breslow test stratified by treatment were used to examine and 
test for differences in time to first time readmission and death for patients with and 
without delirium (Paper III). Cox proportional hazard regression stratified by 
treatment (SAVR/TAVI) was used to adjust for gender, age (as a nonlinear/quadratic 
effect), MMSE and comorbidities (Paper III).
4.5.7 Statistical significance
For all three studies, a two-tailed p- 0.05 was considered statistically 
significant.
4.5.8 Missing data
Missing data can be especially challenging in aging research.89 It was
anticipated that due to the advanced age of the participants in this study, a 
certain amount of missing data would be present. Therefore, a coding system 
for missing was designed (“patient did not answer the item,” “patient 
withdrew from the study,” “patient died,” “administrative reasons prevented 
data collection,” “patient lost-to-follow-up”).
41
By the time 6 month-follow up was performed, 8 of the 136 patients 
discharged alive had died and 9 had withdrew from the study (8 of them 
treated with SAVR) (Figure 1). Cognitive screening 6 months after SAVR or 
TAVI was not performed in 39 patients (29%). Twenty-three of these patients 
did not attend 6-month follow-up at the hospital. The majority of these non-
attendees were living more than 2 hours away from the hospital: 5 stated that 
the hospital was too far away from their residence to attend the consultation, 9 
expressed that they were not well enough to travel, 4 declared that they were 
healthy and did not need further follow-up checks, 3 did not indicate their 
reason for not attending the follow-up, and 2 could not be contacted. Patients
who did not attend their 6-month follow-up did not differ from those 
attending in terms of gender (p = 0.27), baseline comorbidities (p = 0.74), or 
baseline MMSE scores (p = 0.83).
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(Based on figure by Hufthammer KO, 2016)
Figure 1: Flow-chart of included patients.
4.6 Ethical Aspects
CARDELIR was approved by the Regional Committee for Ethics in Medical 
Research in Norway (REK Vest 2010/2936-6) and conducted in accordance with the 
Declaration of Helsinki. Research focusing on old patients brings challenges not 
always present in studies with younger populations. Comorbidities, polypharmacy, 
reduced mobility and sense impairment require special considerations in order to
compel with the ethical principles of beneficence (doing good), non-maleficence,




The principle of beneficence obligates to maximize patients’ benefits.90 91 This
principle was particularly important in included patients who had experienced 
delirium after SAVR or TAVI. Several individuals expressed, in verbal and written 
form, the benefits of having a person with whom they could discuss the experience of 
being delirious. Some felt that this was a difficult issue to talk about with spouses or 
other family members, and were grateful for having a health care professional to 
communicate with.
Another benefit of this study lies in the fact that, as far as we know, it is the first to 
systematically evaluate delirium for five consecutive days in octogenarian patients 
undergoing TAVI and has therefore, the potential of providing benefits for future 
elderly patients undergoing the procedure.
4.6.2 Non-maleficence
Researchers have an obligation to minimize harm.91 This study did not require 
additional blood samples, invasive examination or practices. Nevertheless, it is fair to 
assume that, due to the advanced age of the patients and the nature of the cardiac 
procedures being performed, some individuals might have experienced emotional 
distress. This distress could have increased after they agreed to participate in the 
study. In order to address this issue, only members of the research team with 
extensive experience dealing with geriatric and/or cardiac patients were trusted to 
perform data collection. Whenever verbal and non-verbal signs of discomfort or 
fatigue were identified, data collection was stopped.
4.6.3 Autonomy
The principle of respect for human dignity incorporates the right to self-determination 
and the right to full-disclosure.90 91 All patients received understandable verbal and 
written information about this study at the time of inclusion. They were also informed
about their right to withdraw consent to further participation without giving any 
explanation, or worrying for future treatment or care. Ten patients did not want to 
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participate in the study; TAVI was scheduled in five of them. Additionally, one
patient scheduled for SAVR decided to withdraw consent to further participation
before surgery was performed. By the time of 1-month follow-up, five patients had 
decided to withdraw from the study. By 6-month follow-up, four more had left
(Figure 1).
4.6.4 Justice
The principle of justice is related to the patient’s need for confidentiality and fair 
treatment.90 91 Confidentiality was assured by entering non-identifiable data in a 
secure database provided by Haukeland University Hospital. A list containing 
patients’ name and identification number was placed on a second database with
access restricted to the principal investigation of the CARDELIR-study (TMN) and
the PhD candidate (LSPE). Fair treatment is closely related to the principle of self-
determination. As pointed out earlier, patients received information reassuring them 
that declining to participate in the study would not interfere with the regular care they 
were entitled to receive after surgery or intervention, or in the future. 
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5. Results
The main findings of this study are presented in the following pages.
5.1 Sample characteristics (Paper I-III)
The mean age of the included patients was 83.5 (SD 2.7) and 4 of them were 90 
years-old or older, the oldest being 92 years. The majority of patients were women 
(57%) and married (54%). TAVI was performed in 46% of the patients. Compared to 
patients treated with SAVR, TAVI patients were older (p < 0.001), had lower 
cognitive scores (p = 0.007), more comorbidities (p = 0.001), higher logistic 
EuroSCORE (p < 0.001) and were more often placed in an ASA score between III-IV
(p = 0.001). Detailed information regarding socio-demographic and clinical 
characteristics according to treatment (SAVR vs. TAVI), and presence/absence of 
delirium are presented in Paper I.
5.2 Paper I
Comparison of Frequency, Risk Factors and Time Course of Postoperative 
Delirium in Octogenarians after Transcatheter Aortic Valve Implantation 
versus Surgical Aortic Valve Replacement.
Delirium occurred at least once during the 5 days of evaluation in 56% of patients.
Patients developing delirium were more often treated with SAVR than TAVI (p =
0.01). Delirium was identified in 66% of octogenarians treated with SAVR and in 
44% of those patients treated with TAVI. Multivariate regression analysis established 
that reduced cognitive function (p = 0.003) and treatment with SAVR (p = 0.02) were
risk factors for delirium in octogenarian patients treated for severe AS. 
No differences in the number of days with delirium were identified between patient
groups. Delirium in patients undergoing SAVR lasted on average 1.5 days compared 
to 1.1 days for patients treated with TAVI (p = 0.20). Yet, the course of delirium 
between treatment groups was different (exact logrank test for interval-censored data; 
p = 0.03). Delirium could develop at any time during the 5 days of assessment in
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patients treated with SAVR. Patients in the TAVI group without delirium the first 
postoperative day usually did not develop delirium in the succeeding days.
5.3 Paper II
Delirium as a predictor of Physical and Cognitive Function in Octogenarians 
after Transcatheter or Surgical Aortic Valve Replacement.
Patients treated with SAVR had lower IADL scores at 1-month follow-up,
independently of presence or absence of delirium (from 58 to 42 and from 58
to 50 respectively, p 0.02). Yet, these scores returned to baseline levels by 
the time 6-month follow-up was performed. Improvements in the Physical 
Component Summary score of SF-12 were identified 6 months after SAVR,
especially in patients without delirium (from 39 to 48 p < 0.001). No other
differences in the remaining outcomes were identified. Delirium after SAVR 
could be used to predict IADL function, although it does not predict ADL,
cognitive function, or SF-12 scores. These findings persisted also after 
adjusting for other variables.
TAVI patients with delirium had lower ADL and IADL scores 1 month after 
treatment (from 19 to 16, p < 0.001, and from 49 to 40 p = 0.003 respectively).
The Physical Component Summary scores of SF-12 increased in TAVI 
patients without delirium at 1-month follow-up (from 30 to 35, p = 0.04) and at
6-months follow-up (from 30 to 35, p = 0.02). Regression analyses established 
that delirium following TAVI predicted lower ADL and IADL function only at 
1-month follow-up.
5.4 Paper III
Readmissions and mortality in delirious and non-delirious octogenarian patients 
after aortic valve therapy. A prospective cohort study.
Survival analyses show differences in first-time readmissions and mortality, 1 and 6
months after treatment. When adjusted for type of treatment (SAVR/TAVI), the
differences in readmissions and death between delirious and non-delirious were 
significant 6 months after the initial discharge (p = 0.02). These differences were
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already present during the first month (p=0.006). Initial analyses revealed that the 
effect of delirium was not well described by a Cox proportional hazard model (p =
0.03 in a test for the proportional hazard assumption). Examination of Schoenfeld 
residuals indicated that the effect of delirium on the hazard diminished over time, and 
this was particularly pronounced from about 60 days after initial discharge. We 
therefore fitted a time-dependent effect of delirium, constant up to 60 days (i.e. 
assuming proportional hazards up to this time point) and linear with time from 60 
days. This greatly improved the model fit. Hazard ratio up to 60 days was estimated 
to be 2.9 (95% CI: 1.5 to 5.7). The effect was reduced over time (an estimated 
reduction of about 3% for each day after the 60th).
The majority (24) of the total amount (30) of first-time readmissions 1 month after 
treatment belonged to patients who had experienced delirium. In patients with and 
without delirium, first-time readmissions were related to the circulatory system. One
patient, who did not experience delirium, died within 30 days after treatment. After 6
months, 37 of 58 first-time readmissions belong to patients in the delirium group.




The overall aim of this study was to investigate delirium in octogenarian patients 
undergoing SAVR or TAVI by determining its incidence, identifying risk factors, 
describing its onset and time course, as well as to determine how delirium can predict 
physical and cognitive function, self-reported health status, readmissions and
mortality 1 and 6 months after treatment.
The main results from the papers constituting this study will be first discussed in light 
of methodological issues. Further discussion will be based on previous knowledge 
and future clinical implications.
6.1 Methodological issues
The strength of this study lies in the consecutive inclusion of octogenarian patients 
with severe AS scheduled for SAVR and TAVI. Since Haukeland University Hospital
performs all AVR in western Norway, it is fair to assume that a representative group 
of octogenarian patients from this part of the country and referred to this hospital has
been included. Another strength comes from the psychometric properties of the 
CAM,28 a highly recommended instrument to assess delirium.1 39 40 92 In this study,
contact with included patients was performed by the time of hospitalization, and 
baseline assessments provided the opportunity to make a general assessment of 
cognitive function, arousal and attention that could later be used to evaluate acute and 
fluctuating changes in these areas. CAM was used for five consecutive days, 
including weekends and holidays. Additionally, patients’ hospital records from the 
previous 24 hours were examined closely when CAM was scored. To the best of our 
knowledge, no other study has systematically evaluated delirium exclusively in
octogenarians receiving TAVI, for an equal amount of consecutive days and in two 
follow-up periods. Yet, some limitations that can potentially threat the validity of our
results93 should be acknowledged. These limitations will be discussed on the 
following pages, as appropriate.
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6.1.1 Study design
Prospective cohort and observational studies have strengths and limitations. Some of 
the strengths of this study have been addressed earlier in this chapter. Prospective 
cohort and observational studies have been criticized for being vulnerable to 
confounding factors and for not holding the same position as randomized control 
trials (RCT) in the hierarchical “pyramid of evidence”.94 However, in the present
study, a RCT was not possible since SAVR and TAVI are designed to treat two 
different patient groups.13 Additionally, in recent years, well-designed observational 
studies have been considered to provide results comparable to RCTs.94
6.1.2 Sample
In a prospective study, researchers should be confident that all participants are free 
from the effect that a potential independent variable might impose on a dependent 
variable.95 The prevalence of delirium in the general population is relatively low,35
although it increases with age in clinical settings.36 In this study, the presence/absence 
of delirium was measured only in the postoperative phase. Therefore, we cannot be 
completely sure that all included patients were free from delirium by the time they 
arrived to the hospital. Although MMSE was part of baseline measurement, this 
instrument is insufficient to identify delirium.39 96 Yet, as early mentioned, data 
collection at baseline provided the opportunity to make an overall assessment of 
patients cognitive function, arousal and attention. Other instruments could have been 
used to evaluate delirium at baseline, but at the time the study was designed we 
considered that this might have imposed an extra burden in the octogenarian patients 
included in our study.
The field of cardiology is facing challenges in an increasing older population.97
Increased knowledge in the area is needed, as several cardiac guidelines and 
standards of care are designed for younger population groups.5 98 Our hospital is the 
only one entitled to provide advanced cardiac treatments, such as SAVR and TAVI in
a region of approximately 1.3 million inhabitants99, allowing our research group to 
focus on octogenarians with AS referred to the hospital, and to achieve the 
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homogeneity needed to study delirium after SAVR and TAVI in this patient group. 
This study includes data from 143 of 147 eligible patients (97%), 80 years-old and 
older, with severe AS and living on the west part of Norway. Even though the 
homogeneity of our patient group gives strength in terms of internal validity, it might
also pose a threat to external validity since the results might have limited applicability 
to patient populations undergoing other invasive treatments.93 Yet, it is important to 
emphasize that the high participation rate of octogenarian patients poses strength to 
external validity for octogenarian patients in need of SAVR or TAVI in other hospital 
settings.
The fact that the majority of patients in this study had a good cognitive and ADL 
function might also be a threat to external validity. Even though the high scores in the 
Barthel Index and the MMSE might suggest a patient selection bias before referral to 
our hospital (Paper I-III), this was an issue difficult for us to control.
According to Polit and Beck (2012), statistical conclusion validity “concerns the 
validity of inferences that there truly is an empirical relationship between the
presumed cause and effect” (page 236). In 2010, by the time the study was designed,
a power analysis based on previous research on cardiac surgery populations and the 
primary outcome (delirium/non-delirium) was performed. According to this 
calculation, 100 patients undergoing SAVR and 40 undergoing TAVI would be
needed to reach a statistical power of 80%. These numbers would allow detecting a 
reliable risk difference, given that 31% of patients in the SAVR group and 10% in the 
TAVI group actually developed delirium. However, after two years of inclusion, it 
became clear that a lower number of octogenarians, than we had initially anticipated,
were treated with SAVR. At the same time, more patients were offered TAVI. A new
power calculation was performed and it determined that by including 84 patients in
the SAVR group and 65 patients in the TAVI group we would be able to achieve a
power of 89% to detect a reliable risk difference given that 31% of patients in the 
SAVR group and 10% in the TAVI group actually developed delirium.71




The instruments in this study are proven valid and reliable, yet some limitations 
should be taken into consideration. The CAM has been used in previous Norwegian 
studies,22 49 96 100 101 however it remains to be validated to Norwegian settings. Despite
this minus, the CAM was considered the most appropriate instrument in our study as
it has been widely used, either in its original form or in as CAM-ICU, to identify 
delirium in older cardiac patients.14 15 17 21 50 102 The CAM was recently validated for 
cardiac patients 70 years-old and older in Sweden, reporting a sensitivity of 68% and 
a specificity of 90% indicating false-negative rather than false-positive results for 
delirium.103 These two Scandinavian countries have several similarities, and it is fair 
to assume that the results from Sweden are applicable to Norway. A second limitation
regarding assessment is the lack of instruments evaluating levels of arousal in patients 
with delirium.104 105 Scales such as The Glasgow Coma Scale106 or the Richmond 
Agitation-Sedation Scale107 could have complemented our data. However, by the time
the study protocol was designed, we considered that the battery of instruments and 
measurements was extensive enough considering the age of our group.
Construct validity refers to the degree to which “an investigator believes that his 
instrument reflects a particular construct.”108 A threat to construct validity can be 
found in the fact that the author of this study had a major responsibility for assessing 
the presence/absence of delirium. Other members of the research team performed 
assessment of delirium but we did not examine inter observer reproducibility of 
delirium diagnosis. We attempted to minimize the threat by following guidelines,28
having strict timeframes as to when to assess delirium and by reviewing patient
medical records. In case of uncertainty regarding the presence/absence of delirium, an 
experienced geriatrician (AHR) was consulted to review the information available 
about symptoms of delirium.
The high ADL and cognitive scores provided by the Barthel Index and the MMSE 
might represent a selection bias probably present before patients were referred to our 
hospital. The use of the Nottingham IADL scale might have helped to attenuate these 
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high scores, especially in terms of ADL function. The internal consistency of 
Nottingham IADL scale in this study was of 0.84. The range of internal consistency 
values can be placed between 0.00 to +1.00, with higher values reflecting higher
internal consistency.109 Values between 0.7 to 0.8 are considered satisfactory.110
The SF-12 has been used to evaluate subjective general health and it has provided 
important results regarding health related quality of life in cardiac patients after the
use TAVI.111 112 Although, as far as we know, it remains to be used to detect changes 
between baseline and follow-up times in older cardiac populations that had 
experienced delirium.
6.1.4 Follow-up data
The relatively short follow-up times in this study might limit its internal validity.93
This is especially relevant in terms of the instruments used to evaluate ADL, IADL, 
cognitive function and self-reported health status, as we cannot be sure that patients 
were able to remember some of the questions and that their responses were adjusted
accordingly. We could have performed other measurements or scheduled follow-up
times with longer intervals, yet, follow-up times were planned according to ordinary 
clinical follow-up. The advanced age of our patients also contributed to limit the 
length and number of follow-up times in this study. Besides, other studies have used 
similar follow-up times, providing the opportunity to compare our results with those
obtained by other important publications.17 21 55 The objectivity of this study can have 
been threatened by the fact that the author was present during follow-up times. We 
intended to minimize the threat by using robust instruments to evaluate ADL (Barthel 
Index),76 77 79 IADL (Nottingham IADL)80 113 114, cognitive function (MMSE)74 115 and
self-reported health status (SF-12)85 116 at baseline and follow-up times.
6.1.5 Quality of the data
Data was entered in a secure database. At the end of the inclusion period, a person 
different from the one who had entered the data, checked its quality and guarantee 
that it had been typed correctly. When errors were present, data was rectified and 
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mistakes documented in an independent logbook. Before statistical analyses were
performed, data was screened and controlled for outliers or odd numbers (Paper I-
III).
6.1.6 Missing data
A threat to internal validity93 is loss of data due missing units (questionnaires) and 
items, drop-outs and mortality. As reported earlier (Chapter 3, part 3.5.8 Missing 
data), a coding system for missing data was implemented. Baseline data shows no
missing units or items on the Barthel Index or in the MMSE. Complete units of
Nottingham IADL were identified in 83% of included patients. Yet, 10% did not 
answer 1 item, 1% did not answer 2 and 5% did not answer any of the IADL-items. 
No differences in terms of gender (p = 0.27), marital status (p = 1.00), education (p =
0.14), comorbidity (p = 0.14) or AS treatment (p = 0.82) were found between patients
with complete units vs. those with incomplete units. Regarding baseline data for SF-
12, 85% of patients had complete units, 7% did not answer any of the 12 items, 4% 
did not answer 1 item and 1% did not answered 3, 6 or 7 items. Those with 
incomplete SF-12 units were more often males (p=0.02). No differences in marital 
status (p = 0.81), education (p = 1.00), comorbidity (p = 0.355) or treatment were 
identified (p = 0.47) (Paper I - III).
At 1-month follow-up, 87% of patients had complete Barthel Index units. No missing 
items were found. Complete Nottingham IADL units were identified in 63% of 
patients, while 20% did not answer any item, 11% did not answer 1 item, 3% did not 
answer 2 and 1% did not answer 3, 6 and 7 items. On the SF-12, 69% of patients had 
complete units, 20% did not answer 12 items, 8% did not answer 1 item, 3% did not 
answer 2 and 1% did not answer 6 items (Paper II).
At 6-month follow-up, 83% of patients completed the Barthel Index unit. Remaining 
patients did not answer any of the items on the index. Nottingham IADL was 
completed by 63% of patients, 23% did not answered any of the items, 10% did not 
answered 1 item, 1% did not answer 2 and 2% did not answer 3. Complete SF-12 
units were found in 69% of patients, 24% did not answer any item, 8% did not answer 
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1 item and 2% did not answer 2 items. MMSE at 6-month follow-up was not 
performed in 45 patients (31%), who for different reasons did not attend 6-month 
follow-up at the hospital. The majority of those non-attendees, were living more than 
two hours away from the hospital: 5 stated that the hospital was too far away from 
their residence to attend the consultation, 9 expressed that they were not fit enough to 
travel, 4 declared that they were healthy and did not need further controls, 3 did not 
want to indicate the motive for not attending follow-up, and 2 patients were unable to 
be contacted. Of the remaining patients without MMSE scores at 6-month follow-up,
9 withdrew from the study and 13 were dead. Patients who did not attend 6-month 
follow-up did not differ from those attending in terms of sex (p = 0.27), baseline 
comorbidities (p = 0.74) or baseline MMSE scores (p = 0.83).
Missing data is specially challenging in research that involves older patients.89 Close
examination of missing data and use of statistical techniques allowing account for 
death or dropout have been warranted.117 In order to reduce missing data in our study,
telephone contact with included patients was attempted before follow-up
consultations and self-rapport questionnaires were send by mail to patients unable to 
attend the follow-up consultation. Together with the questionnaires, a pre-stamped 
and pre-addressed return envelope was provided. When data analysis was performed,
sensitivity analysis was used to manage the challenging issue of missing data.
6.2 Discussion of main findings
This study provides additional evidence placing delirium as an unwanted outcome in
older hospitalized adults.1 As the number of older individuals in need of treatment for 
severe AS is raising, 8 59 60 and TAVI is successfully being performed in patients 80
years-old and older,60 118 it is important to address the high incidence of delirium
found in hospital settings and discuss the differences in the course of delirium
between patients treated with SAVR and TAVI. The lower levels of performance in 
terms of physical and cognitive function for patients having delirium, especially those
treated with TAVI, might suggest a vulnerability in this patient group that has not 
been properly uncovered. This study also provides valuable knowledge by 
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determining that delirium can be used to predict first-time hospital readmissions and 
mortality in octogenarian patients 1 and 6 months after treatment with SAVR or
TAVI. The knowledge presented in this study could be used by health care 
professionals and administrators of health care systems to design and implement 
strategies directed to prevent and reduce the personal and socioeconomic costs of 
delirium.
6.2.1 Development and course of delirium after SAVR versus TAVI
A high incidence of delirium was found in patients 80 years and older after treatment,
especially in the group of patients treated with SAVR. In this study, SAVR not only 
emerged as a new risk factor for delirium in our sample, but was also associated with 
a more unpredictable onset and course. These findings are of interest, taking into 
consideration that several risk factors for delirium, such as higher age, lower 
cognitive scores, higher number of comorbidities and higher operative risk 14 15 17 119
were more often found among patients in the TAVI group.
A possible explanation to the higher incidence of delirium in an apparently less
vulnerable population can be found in the more aggressive treatment approach SAVR 
represents, and in the multifactorial causation model of delirium.1 As explained by 
Inouye and colleagues, each episode of delirium might have a unique set of 
contributors, and each set is composed by several interacting factors that might 
eventually lead to it.1 In the light of the multifactorial model, several postoperative 
patterns differentiate patients treated with SAVR to those treated with TAVI; reduced 
mobility due to the invasive SAVR procedure and use of physical restraints, and
inflammation. Physical restrains are one of the leading predisposing factors for 
delirium in medical inpatients.1 SAVR requires an aggressive approach with general 
anesthesia, sternotomy and extracorporeal circulation. Consequently, patients treated 
with SAVR use cardiac monitoring devices, intravenous lines and urine catheters that 
might reduce their mobility for longer periods of time. Direct brain insults and
aberrant stress responses have been proposed as two basic etiological factors leading 
to delirium.120 Although a deep analysis of the complex brain function (or 
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dysfunction) related to delirium is beyond the scope of this study, is worth 
mentioning that pathologically sustained elevated cortisol levels, like those occurring 
with inflammation and acute stress from surgery and pain, might precipitate 
delirium.120,121 TAVI can be performed without general anesthesia, and the more
gentle technique that characterizes TAVI might lead to less tissue damage, potentially
less inflammation and reduced patient distress. It can partially explain why in our 
population group, SAVR patients developed more delirium despite the fact that 
patients in the TAVI group had several predisposing factors. This might also imply 
that health care professionals should be more aware of sudden and fluctuating 
changes in attention and cognition for patients receiving SAVR, and strategies for 
prevention, early detection and treatment of delirium should be part of hospitals 
guidelines and protocols.
No differences in the number of days with delirium between patient treated with 
SAVR or TAVI were identified. However, we were able to determine that the
majority of patients in the TAVI group developed delirium during the first 
postoperative day, while delirium could develop at any time during the five days of 
assessment for patients in the SAVR group (Paper I, Figure 2). As far as we know, 
no other study has systematically studied the onset and course of delirium,
consecutively for 5 days and focusing on octogenarians undergoing aortic valve 
treatment. This approach enabled the identification of such a distinction. An
explanation to the differences in onset and course could be found in the possible 
relationship between physical restraints and delirium.1 In the setting in which this 
study was conducted, cardiac monitoring equipment and urine catheters in TAVI 
patients are often removed after the first 24 hours. Additionally, our hospital 
protocols strongly encourage mobility in patients undergoing TAVI. Mobility is also 
promoted for SAVR patients, and nurses and physiotherapist work hard assuring
appropriate levels of activity in surgical patients. Yet, the presence of several other
precipitating risk factors for delirium such as; inflammation,121 sleep disturbances,122
use of psychoactive drugs such as sedatives and opioids,123 together with physical
restraints124 might place an extra burden that, for this particular group of patients, will
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lead to a more unpredictable onset of delirium. Note, however, that our findings are 
limited by our small sample and demand further studies.
6.2.2 Physical and cognitive function following hospital discharge
for patients with and without delirium.
All patients in the SAVR group, had reductions in ADL function 1-month after 
treatment for AS being this reduction statistically significant in patients without 
delirium. Abrupt falls in ADL function at 1-month follow-up were identified for 
patients in the TAVI-group with delirium, while ADL scores in TAVI patients
without delirium remained stable both at 1 and 6-month follow-up. Even though ADL
scores increased in all patient groups by the time 6-month follow-up was performed, 
a distinct trend to lower ADL performance can be seen in TAVI patients who had
delirium (Paper II, Figure 1). A reduction in ADL function can be expected in 
octogenarian patients undergoing the more aggressive SAVR. The physical burden of 
the SAVR treatment is higher during their hospital stay because of the use of general 
anesthesia, cardiopulmonary bypass, sternotomy and cardio monitoring devices. By 
the time of hospital discharge, sternotomy might still limit the performance of ADL 
in areas such as taking a shower or dressing. It is however interesting to see that
patients treated with TAVI and experiencing delirium also had big reductions in ADL 
scores.
Delirium has been associated with poor physical17 21 50 and cognitive outcomes.1 21 54 55
A recent review article125 explores the association between acute critical illness, 
reduced physical function and delirium. The authors underline the need to reduce 
immobility and delirium in hospitalized critically ill older patients, claiming that 
changes in the structure and function of skeletal muscle make elderly more vulnerable 
to develop physical disability when immobility and delirium are present.125 This
theory finds support in one of the most interesting results from our study; the stable 
ADL scores of TAVI patients without delirium at 1 and 6-month follow-up. ADL 
performance in octogenarian patients undergoing the more invasive SAVR did not 
show the same degree of decrease, even though a borderline decrement at 1-month 
follow-up can be seen in SAVR patients without delirium. These findings might 
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imply that TAVI patients who experienced delirium were more vulnerable, and that 
especial strategies should be designed not only to identify patients at risk to develop 
delirium but also to increase the physiological resources of these patients. Increased 
focus on early mobility and their benefits should also be taken into consideration 
when older patients are schedule for treatment for AS.
Significantly lower IADL scores were found in patients developing delirium in both
treatment groups (SAVR/TAVI). IADL scores in TAVI patients without delirium 
remained constant at both follow-up points, following the same pattern as for ADL 
scores (Paper II, Figure 1). These findings are of particular interest, as IADL 
function measures levels of performance in activities that are more dependent on 
intact cognitive functioning, such as the use of public transportation or managing own 
money.17
Cognitive function is an important outcome for older patients. Our data shows a
patient group with high levels of cognitive performance compared to, for example,
hip fracture patients.126 We did not find significant differences between baseline and 
6-month follow-up in any of the treatment groups, supporting findings from other 
studies.54 55 However, note that MMSE scores in TAVI patients with delirium were 
lower at baseline and remained low at 6 months follow-up (Paper II, Figure 1).
Variations in cognitive scores beyond 1-month follow-up remain inconclusive,127, 54 55
and strategies to identify patients at risk and approaches aimed to reduce the risk of 
developing delirium should be part of hospital setting where SAVR and TAVI are 
performed. 
6.2.3 Self-reported health status following delirium, SAVR and 
TAVI
SF-12 Physical Component Summary
Lower (yet non-significant) scores at 1-month follow-up, compared to baseline, and 
significant increases 6 months after treatment were present in SAVR patients,
independently of delirium. PCS scores increased in all TAVI patients, being these 
statistically significant for individuals who did not experience delirium (Figure 1, 
59
Paper II). The lower self-reported scores for SAVR patients can be related to the 
more aggressive approach of the treatment that included more tissue damage, higher 
levels of inflammation, reduced levels of mobility and bed rest for longer periods of 
time. Immobilization over prolonged periods of time results on lower muscle strength 
and reduced aerobic capacity in healthy adults.128 Patients admitted to critical care 
units also experience reductions in bone mineral density and impairment in other 
body systems.129
Octogenarian patients with and without delirium after SAVR reported reduced levels 
of physical function at 1-month follow-up, as these patients had already done when 
scoring the Nottingham IADL scale. Yet the PCS scores improved notable after 6 
months, especially for patients without delirium. The moderated but steady increase
in PCS scores from baseline to 1-month follow-up and further on after 6 months for 
all patients undergoing TAVI might also reflect baseline vulnerability in this patient 
group that requires more time to recover. Our findings are consistent with studies 
showing improvements in the PCS scores of SF-12 for patients undergoing TAVI,
although the increases in our patient group, despite being significant, are not as high 
as the other studies presented.111 112 130 It is possible that the inclusion of delirium in 
our analyses contributed to reveal an additional element, partly responsible for this
difference (Paper II). Current guidelines regarding older patients with cardiovascular 
diseases98 advocate for the inclusion of health status and quality of life because these
measurements provide important information regarding physical functioning in older
hospitalized patients.131 Therefore patient-reported outcomes should also be part of 
risk assessment in settings where older adults are receiving treatment for AS with 
SAVR or TAVI.
SF-12 Mental Component Summary
A continuous increase in MCS scores, from baseline to 1 and 6-month follow-up, was
found in patients experiencing delirium after TAVI. The remaining groups showed
patterns that crossed each other (Figure 1, Paper II). Note, however, that baseline
MCS scores for TAVI patients are as low (baseline score: 47) as the lowest scores 
present in SAVR patients (those who experienced delirium at 30 days: 47.1),
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indicating once more the underline vulnerability of octogenarians undergoing TAVI.
Another interesting aspect is that baseline MCS scores in the TAVI group are higher 
than those reported in an European study including elderly patients treated with TAVI
and which did not find significant differences between baseline scores and 1 and 6-
month follow-up.111 These results might reflect the diversity present in older
populations,5 but they can also depict the mental distressing experience of having 
delirium.132 Patient reported outcomes are particularly important in this field and
strong efforts should be made to increase knowledge regarding delirium and its 
association with mental health.
6.2.4 Readmissions and mortality. The impact of delirium following 
SAVR and TAVI.
The number of first-time readmissions was higher 1 and 6 months after treatment in
octogenarian patients belonging to the delirium group (Paper III Figure 2), and the 
majority of deaths 6 months after treatment were found in patients who experienced 
delirium. It is difficult to be entirely certain on whether delirium leads to an 
additional vulnerability that is reflected on the higher number of readmissions, or if 
these patients were vulnerable at baseline and this is reflected upon the development 
of delirium and later readmissions. It is somehow puzzling that SAVR and TAVI 
patients without delirium had the lowest risk for readmissions and mortality 6 months 
after discharge (Paper III, Figure 3), and this might support the assumption of 
delirium imposing an extra burden in octogenarian patients, especially during the first 
two months after treatment. These findings are supported by a recent study showing 
that delirium was associated with higher rates of adverse outcomes in older patients
undergoing elective surgery.20 Studies evaluating the impact of delirium, exclusively 
in elderly after SAVR or TAVI, are scarce. A literature review done as late as April 
15th 2016, shows the work of Maniar et al133 as the only one exploring delirium and
mortality in SAVR and TAVI patients. This study found a 3-fold increased risk of 
mortality during the first year after AVR. Despite the increased interest in delirium, 
larger studies with longer follow-up times are necessary in order to establish possible 
changes in the rates of readmissions and mortality. It is also of interest to study the
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course of disability in the last years of life in delirious and non-delirious octogenarian 
patients after treatment for severe AS. For health care professionals these findings 
emphasize the importance of prevention and identification of patients at risk of 
having delirium.
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7. Conclusion and implications
7.1 Conclusions
Conclusions from the three papers that constitute this study are:
The incidence of delirium in octogenarians after aortic valve treatment is high,
especially for those receiving SAVR. This treatment also emerged as a 
predisposing factor for delirium. According to our data, a more unpredictable 
onset and course of delirium could be expected when SAVR was used (Paper
I).
Delirium after SAVR and TAVI is followed by short-term reduction in IADL
function. However, it does not seem to confer long-term reductions in 
physical, mental or self-reported health (Paper II).
The number of first-time readmissions and death 1 and 6 months after aortic
valve treatment was higher in octogenarian patients who experienced delirium 
(Paper III).
Delirium is a major postoperative complication that might predict lower IADL 
performance and a higher risk of hospital readmissions and death in octogenarian 
patients following treatment for AS with SAVR or TAVI. 
7.2 Implications of the study
Delirium is a serious phenomenon that can lead to unwanted outcomes, both during
the initial hospital stay and within the first 6 months after AVR. The implications that 
delirium has on socioeconomically levels, clinical contexts and on the individual 
sphere are of big importance. The prevalence of AS increases with age and it is fair to 
anticipate that older patients, more often than before, will be recipients of advanced 
cardiac treatments such as SAVR and TAVI. This implies that delirium after
cardiothoracic surgery or intervention will be more often present in hospital settings.
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Increased knowledge on all levels of patient care is required to prevent and address 
delirium. Health care systems should be aware about the incidence, potential risk 
factors and consequences of delirium in octogenarian cardiac patients. This 
knowledge could provide health care administrators with the opportunity to envision 
future challenges and to design strategies to prevent delirium and prompt early 
intervention. The quality of care that our patients receive could be enhanced if health
care providers are aware of delirium as a phenomenon that is common and that could 
lead to potentially serious outcomes.
Identification of patients at risk of developing delirium, tools to prevent its 
development, recognition and management of its features demand an interdisciplinary 
approach.134 This was emphasised in a recent publication supporting multicomponent 
interventions68. Nurses, physicians and physiotherapist are some of several
professions in close contact with hospitalized patients and having an important task in
the prevention and identification of delirium in cardio surgery departments.
Educational programs focusing on delirium could be an important addition to 
introduction courses for new employees and the information provided in these 
courses could be complemented with regular reminders about delirium and its 
features.134-136 E-learning has also provided a way to increase knowledge 137 that
should be further studied. The inclusion of personal with geriatric knowledge into a 
cardiac surgery ward could also provide valuable contributions that will eventually 
help to identify and reduce the incidence of delirium in hospital settings.
Older cardiac patients and their families might also benefit from information 
regarding delirium and its features. Increased knowledge about this phenomenon 
might help patients and their relatives to rapidly identify acute changes in arousal, 
attention and cognition that could, otherwise, take longer time for health care 
professionals to be aware of. This knowledge could also help to diminish the anxiety 
that patients and relatives might experience when delirium appears.
Special efforts should be made to provide a secure environment that could reduce the 
development of delirium, independently of treatment. Precipitating factors for 
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delirium have the potential of being modifiable.37 Correction of sense impairment
(use of adequate corrective glasses and hearing aids), adequate environment for easy 
reorientation (calendars, clocks, daylight) reduction in sleep disturbances, pain
control, correct balance between activity and bed rest, and treatment of underlying 
causes that might cause delirium are some of the multidisciplinary strategies that 
could be implemented to reduce the development of delirium.134 135 In a thoracic
surgery unit, patients treated with SAVR, having long intubation times, blood 
transfusion and abnormal albumin levels should be closely followed. For future 
octogenarians, as important as the type of AS treatment is the identification of 
modifiable risk factors and actions that could prevent delirium not only after AS 
treatment but also while waiting to receive SAVR or TAVI.
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8. Suggestions for further research
Several issues emerge from our findings. From a macro to an individual level they 
can be placed as follows:
Studies with larger populations and longer follow-up times are needed to 
establish if the rates of first-time readmissions and death, according to 
delirium status, are comparable with other patient groups.
Additional prospective studies about delirium following less invasive cardiac 
procedures are needed. Minimally invasive aortic valve surgery, for example is
a new treatment form that should be closely examined in terms of delirium.
Prevention strategies could help to reduce the incidence of delirium. Whether 
these strategies lead to less delirium in elderly patients receiving the more 
invasive SAVR compared to those who are treated with TAVI require further 
investigation.
Research is needed to evaluate the severity of delirium after treatment with 
SAVR and TAVI, and the possible implications that the levels of intensity can 
have in short and long term outcomes for older patients.
Increased knowledge in patients and families about delirium, can lead to early
identification. This issue should be systematically studied.
Further research focusing on SF-12, older cardiac patients and delirium should 
be prioritized.
The use of patient reported outcomes within delirium have not been enough 
studied. Strong efforts should be made to increase the knowledge that patient
reported outcomes in cardiology have within the field of delirium.
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Comparison of Frequency, Risk Factors, and Time Course
of Postoperative Delirium in Octogenarians After
Transcatheter Aortic Valve Implantation Versus Surgical Aortic
Valve Replacement
Leslie S.P. Eide, RN, MAa,*, Anette H. Ranhoff, MD, PhDa,b, Bengt Fridlund, RNT, PhDc,
Rune Haaverstad, MD, PhDa,d, Karl Ove Hufthammer, PhDe, Karel K.J. Kuiper, MD, PhDd,
Jan Erik Nordrehaug, MD, PhDa,f, and Tone M. Norekvål, RN, PhDa,d,
On behalf of the CARDELIR Investigators
Postoperative delirium (PD) after transcatheter aortic valve implantation (TAVI) remains to
be explored.We sought to (1) determine the incidence of PD in octogenarians who underwent
TAVI or surgical aortic valve replacement (SAVR), (2) identify its risk factors, and (3)
describe possible differences in the onset and course of PD between treatment groups. A
prospective cohort study of consecutive patients aged ‡80 years with severe aortic stenosis
who underwent elective TAVI or SAVR (N[ 143) was conducted. The incidence of PD was
assessed for 5 days using the Confusion AssessmentMethod (CAM). Risk factors for PDwere
studied with logistic regression. Patients treated with TAVI were older (p £0.001), had lower
cognitive scores (p[ 0.007), and more co-morbidities (p[ 0.003). Despite this, significantly
fewer (p [ 0.013) patients treated with TAVI (44%) experienced PD compared to patients
treatedwith SAVR (66%). Undergoing SAVR (p[ 0.02) and having lower cognitive function
(p [ 0.03) emerged as risk factors for PD, whereas gender, activities of daily living, frailty,
atrial fibrillation, and postoperative use of opioids and anxiolytics did not. Patients treated
with TAVI and without PD during the first 2 postoperative days were unlikely to experience
PD on subsequent days. The onset of PD after SAVR could occur at any time during the
postoperative evaluation. In conclusion, SAVR in octogenarian patients with aortic stenosis
might be considered as a predisposing factor for PD.Our data also suggest that the onset of PD
wasmore unpredictable after SAVR.  2015TheAuthors. Published byElsevier Inc. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/) (Am J Cardiol 2015;-:-e-)
Older patients undergoing cardiac surgery often develop
postoperative delirium (PD).1 Transcatheter aortic valve im-
plantation (TAVI) is offered to patients with aortic stenosis
(AS) without reasonable surgical alternatives.2 Many TAVI
patients are 80 years and older.3 Delirium, an acute and fluc-
tuating change in cognition and attention,4 is often associated
with adverse short- and long-term health implications.5,6
Although the cause of PD is not fully understood, it is known
that impairment in cognition and activities of daily living
(ADL), advanced age, co-morbidities, preoperative atrial
fibrillation (AF), major surgery, and use of opioids and
benzodiazepines are risk factors.4,7,8 The relation between PD
and the patients’ status score in The American Society of An-
esthesiologists (ASA) Physical Status Classification System,
logistic EuroScore,9 and general anesthesia has been ques-
tioned.10 Frailty11 is a predictor of adverse health outcomes and
death in the elderly,12 but whether frailty is also a risk factor for
PD in octogenarian patients with AS remains to be established.
Because TAVI is a less-invasive treatment currently offered to
individuals with higher surgical risk, it is warranted to inves-
tigate if patients undergoing TAVI are less likely to develop
PD. Knowledge about octogenarians undergoing invasive
cardiovascular therapy is scarce. Although the incidence of PD
after cardiac surgery has been explored,1,13,14 these studies
included younger patients (<80 years) needing coronary artery
bypassgrafting (CABG)alone or combinedwith surgical aortic
valve replacement (SAVR). Further predisposing factors can
be identified by restricting the study population to octogenar-
ians with severe AS who underwent elective treatment. A
recent study15 described the incidence of PD after TAVI,
studying only the first postoperative day and including few
octogenarians. Therefore, the aims of this study were to (1)
determine the incidence of PD in octogenarians with AS
requiring SAVR or TAVI, (2) identify risk factors for its
development, and (3) describe possible differences in the onset
and course of PD in the 2 treatment groups.
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We conducted an observational, prospective cohort study
of consecutive octogenarian patients who had undergone
elective TAVI or SAVR in a tertiary university hospital in
western Norway. Patients aged 80 years and older previously
accepted for TAVI or SAVR were eligible. The study was
entitled “Delirium in octogenarians undergoing cardiac sur-
gery or intervention (CARDELIR)”, and presence of
delirium was the primary outcome. A group of experts in
cardiothoracic surgery and invasive cardiology evaluated
octogenarian patients with AS and identified those not suit-
able for SAVR. Exclusion criteria were inability to speak and
understand Norwegian and declining consent to participate.
Severe AS was defined as aortic valve area <0.6 cm2/m2,
mean gradient of >40 mm Hg, and maximum jet velocity
>4.0 m/s.16 The main reasons disqualifying patients for
standard SAVR included previous CABG, severe respiratory
insufficiency, co-morbidities that could compromise recov-
ery, and previous thoracic radiotherapy. From February 2011
to August 2013, 162 octogenarians were admitted for TAVI
or SAVR. Of these, 147 fulfilled the eligibility criteria and
144 agreed to participate. One patient withdrew consent
before surgery, and 7 were either not responsive or died
within 5 days after treatment, leaving us with data for 136
patients (Figures 1 and 2). One patient who underwent TAVI
was discharged on the fourth postoperative day.
Assessment of the presence of PD was performed with the
Confusion Assessment Method (CAM).17 CAM is based on
operationalized criteria derived from the Diagnostic and Sta-
tistical Manual of Mental Disorders (DSM-IV) and assesses 4
features: (1) acute-onset and fluctuating course, (2) inattention,
(3) disorganized thinking, and (4) altered level of conscious-
ness. Delirium is diagnosed when features 1 and 2 are present
and either 3 or 4 are displayed.17 The accuracy of CAM has
Figure 1. Recruitment flow diagram of octogenarian aortic stenosis patients
who underwent TAVI or SAVR.
Figure 2. Diagram of TAVI and SAVR patient (N ¼ 143) status, displayed
sequentially for each postoperative day.
2 The American Journal of Cardiology (www.ajconline.org)
been confirmed in several studies.18 We studied this primary
outcome as the presence of PD on daily basis and as the pres-
ence of PD in a period of 5 days after AS treatment.
ADL function, atrial fibrillation, cognitive function,
co-morbidity, and postoperative use of opioids and
anxiolytics as potential risk factors for PD were selected on
the basis of review of reports4,7,18,19 and clinical experience.
Treatment with TAVI and baseline frailty were also
included in the regression analysis. We assessed patient’s
self-care abilities with the Barthel Index20 which evaluates
Table 1



















Age (years) 83.5 2.7 83.4 2.8 83.5 2.7 0.76
Women 81 (57%) 37 (62%) 39 (51%) 0.23
Marital Status 0.68
Married 77 (54%) 31 (52%) 42 (55%)
Cohabital status 0.21
Live alone 67 (47%) 31 (53%) 31 (41%)
SOF Frailty Index 0.36
Robust 48 (34%) 19 (32%) 27 (36%)
Prefrail 39 (27%) 20 (33%) 17 (22%)
Frail 56 (39%) 21 (35%) 32 (42%)
MMSE 27.2 2.9 27.6 2.3 26.9 3.3 0.14
MMSE27 63 (44%) 24 (40%) 34 (45%) 0.58
BI 18.9 1.5 19.2 1.4 18.8 1.5 0.11
BI18 44 (31%) 16 (27%) 26 (34%) 0.34
BMI (Kg/m2) 25.5 4.1 25.4 4.8 25.6 3.8 0.72
BMI (Kg/m2) 20 13 (9%) 8 (13%) 5 (7%) 0.18
Charlson Comorbidity Index 2.1 1.2 2.1 1.2 2.1 1.2 0.91
Logistic EuroScore* 14.0 (9.2%) 15.4 (9.3%) 12.9 (9.1%) 0.11
NYHA function class 0.33
I-II 48 (38%) 19 (34%) 28 (42%)
III-IV 80 (62%) 37 (66%) 38 (58%)
Left ventricle ejection fraction (%) 56.4 10.3 56.4 11.1 56.6 9.7 0.89
Max aorta gradient (mmHg) 79.3 24.9 78.6 25.5 79.4 24.1 0.85
Mean aorta gradient (mmHg) 48.2 16.6 48.0 16.5 48.1 16.5 0.99
Aortic valve area (cm2/m2) 0.4 0.2 0.4 0.1 0.4 0.2 0.30
Preoperative atrial fibrillation 39 (27%) 14 (23%) 25 (33%) 0.22
Hemoglobin (g/dL) 13.1 1.4 13.0 1.3 13.2 1.5 0.25
Creatinine concentration, (mmol) 91.3 27.8 88.6 26.7 93.2 26.9 0.32
GFR, (mL/min/1.73m2) 54.8 9.0 55.6 8.6 54.5 8.8 0.47
Albumin, (g/L) 44.0 3.0 43.7 2.9 44.2 2.8 0.32
Perioperative variables
Type treatment: TAVI 65 (45%) 35 (58%) 25 (42%) 0.01
ASA-Classification 0.28
III 120 (84%) 48 (80%) 66 (87%)
IV 23 (16%) 12 (20%) 10 (13%)
Anesthesia time (hours) 3.9 1.6 3.4 1.3 4.1 1.5 0.005
Type of anesthesia (sedation) 34 (24%) 20 (33%) 13 (17%) 0.03
Preoperative medication 0.02
Oxazepam (Sobril) 51 (36%) 29 (49%) 21 (28%)
Morfin scopolamine 77 (55%) 24 (41%) 21 (28%)
None 12 (9%) 6 (10%) 5 (7%)
Blood transfusion 29 (20%) 8 (13%) 17 (22%) 0.18
Hypotension 75 (52%) 29 (48%) 41 (54%) 0.52
Tachycardia 8 (6%) 4 (7%) 4 (5%) 0.73
Hypoxia† 6 (4%) 0 (0%) 5 (7%) 0.07
Post-operative medication
Opioids required 117 (83%) 45 (76%) 67 (88%) 0.07
Loop diuretics required 127 (89%) 50 (83%) 73 (96%) 0.01
ASA ¼ American Society of Anesthesiologists; BI ¼ Barthel Index; BMI ¼ Body Mass Index; MMSE ¼Mini Mental Status Examination; NYHA function
class ¼ New York Heart Association Function Classification; SOF ¼ Study of Osteoporotic Fractures; TAVI ¼ transcatheter aortic valve implantation.
* P-value based on log-transformed values.
† Fisher’s exact test.
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ADL in 10 basic areas. This index is reliable and valid21 and
provides a score from 0 to 20, with 19 or more indicating
functional independence.20 General cognitive functioning
was measured with the Mini-Mental State Examination
(MMSE), a 20-item instrument, with maximum score of 30
points.22 Co-morbidities were quantified using the Charlson
comorbidity index. It predicts mortality in patients with co-
morbid disorders, assigning a score of 1, 2, 3, or 6, summed
to predict mortality.23 Several studies have demonstrated the
reliability and validity of the index.23 Frailty was defined
using the Study of Osteoporotic Fractures (SOF) Frailty
Index.12 It identifies subjects at risk of adverse health out-
comes on the basis of weight loss, inability to rise from a
chair 5 times without using his/her arms, and reduced en-
ergy level.24 The SOF Frailty Index classifies patients as
robust, prefrail, or frail. Its psychometrical properties have
been confirmed.12,24 We used patients’ medical records to
identify the presence of preoperative atrial fibrillation, as
assessed by a cardiologist, and to recognize postoperative
use of opioids and anxiolytics.
Table 2


















Age (years) 83.5 2.7 84.8 2.8 82.4 2.0 <0.001
Female 81 (57%) 41 (63%) 40 (51%) 0.16
Marital Status 0.18
Married 77 (54%) 31 (48%) 46 (59%)
Cohabital status 0.13
Live alone 67 (47%) 35 (54%) 32 (41%)
SOF- Frailty Index 0.11
Robust 48 (34%) 16 (25%) 32 (41%)
Prefrail 39 (27%) 21 (32%) 18 (23%)
Frail 56 (27%) 28 (43%) 28 (36%)
MMSE 27.2 2.9 26.5 3.1 27.8 2.6 0.007
MMSE27 63 (44%) 36 (55%) 27 (35%) 0.01
BI mean 18.9 1.5 18.8 1.5 19.0 1.5 0.37
BI18 44 (31%) 23 (35%) 21 (27%) 0.27
BMI (Kg/m2) 25.5 4.1 25.0 4.4 25.9 3.9 0.20
BMI20 13 (9%) 9 (14%) 4 (5%) 0.07
Charlson Comorbidity index 2.1 1.2 2.5 1.3 1.8 1.0 <0.001
Logistic EuroScore* 14.0 9.2 19.6 10.6 9.4 3.6 <0.001
NYHA function Class <0.001
I-II 48 (38%) 11 (20%) 37 (51%)
III-IV 80 (62%) 45 (80%) 35 (49%)
Left ventricle ejection fraction (%) 56.4 10.3 55.9 10.1 56.8 10.5 0.59
Max aorta gradient (mmHg) 79.3 24.9 74.4 23.8 83.6 25.2 0.03
Mean aorta gradient (mmHg) 48.2 16.6 45.6 16.3 50.6 16.7 0.08
Aortic valve area (cm2/m2 ) 0.4 0.2 0.4 0.1 0.4 0.2 0.64
Preoperative atrial fibrillation 39 (27%) 22 (34%) 17 (22%) 0.11
Hemoglobin (g/dL) 13.1 1.4 12.7 1.6 13.5 0.12 0.001
Creatinine concentration (mmol) 91.3 27.8 93.9 28.1 89.2 27.5 0.32
Albumin, (g/L) 44.0 3.0 43.5 3.0 44.4 2.9 0.07
Perioperative variables
ASA Classification <0.001
III 120 (84%) 44 (68%) 76 (97%)
IV 23 (16%) 21 (32%) 2 (3%)
Anesthesia time (hours) 3.9 1.6 2.8 0.7 4.9 1.5 <0.001
Preoperative medication <0.001
Oxazepam (Sobril) 51 (36%) 50 (81%) 1 (1%)
Morfin scopolamine 77 (55%) 0 (0%) 77 (99%)
None 12 (9%) 12 (19%) 0 (0%)
Blood transfusion 29 (20%) 6 (9%) 23 (29%) 0.003
Tachycardia 8 (6%) 4 (6%) 4 (5%) 0.79
Hypoxia† 6 (4%) 5 (8%) 1 (1%) 0.09
Post-operative medication
Opioids required 117 (83%) 40 (62%) 77 (100%) <0.001
Loop diuretics required 127 (89%) 51 (78%) 76 (99%) <0.001
ASA ¼ American Society of Anesthesiologists Classification; BI ¼ Barthel Index; BMI ¼ Body Mass Index; MMSE ¼ Mini Mental Status Examination;
NYHA Function Class ¼ New York Heart Association Function Classification; SOF ¼ Study of Osteoporotic Fractures.
* P-value based on log-transformed values.
† Fisher’s exact test.
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Patients were approached for consent 1 day before
intervention, and preoperative data were gathered that day.
Demographic and clinical information was collected by
interview or from medical records, as appropriate. ADL and
cognitive function were measured at baseline, and data
needed to score the SOF Frailty Index were collected at this
time. Nursing staff were instructed about PD features
regularly as reminders and were encouraged to report PD
symptoms during every shift. However, research assistants
trained to use the CAM were responsible for assessing PD
after visiting the patients daily at noon, from postoperative
days 1 to 5, including weekends. Patients were assessed for
inattention, disorganized thinking, altered level of con-
sciousness, and disorientation. Medical, nursing, and phys-
iotherapist’ reports from the previous 24 hours and results
from meetings with health professionals in charge of the
study patients were also considered when CAM was scored.
The study was approved by the Regional Committee for
Ethics in Medical Research (REK Vest 2010/2936-6) and
conducted in accordance with the Declaration of Helsinki.
Patients were invited to participate in the study after
receiving oral and written information. Registered nurses
with extensive experience with geriatric and cardiac pa-
tients, but not involved in the care of the patients, were
responsible for enrollment and data collection. Because of
patients’ advanced age and the nature of the procedure, we
were particularly alert for verbal and nonverbal signs indi-
cating displeasure or exhaustion during data collection.
Previous research on cardiac surgery populations and the
primary outcome guided our power analysis. We determined
a priori that 100 patients who underwent SAVR and 40 who
underwent TAVI would be required to reach a statistical
power of 80%, which would allow us to detect a reliable risk
difference, given that 31% of patients in the SAVR group25
and 10% in the TAVI group actually developed delirium.
Because the incidence of PD after TAVI had not been
previously studied, the last percent was estimated. Two
years after the start of the study, fewer eligible patients than
we initially anticipated received SAVR. A new power
analysis showed that including 84 patients who underwent
SAVR and 65 patients who underwent TAVI would give a
power of 89%.
Data are presented as counts and percentages or means
and standard deviations. Differences between groups were
tested with the chi-square or Fisher’s exact tests for cate-
gorical variables and the Welch t test (i.e., a t test not
assuming equal variances) for continuous variables. Logistic
regression was used to determine the impact of proposed risk
factors on PD. A log-rank test for interval-censored data26,27
was used to study differences in the time to onset of delirium.
Statistical analyses were performed using IBM SPSS
Statistics for Windows, version 21.0 (IBM Corp., Armonk,
NY), and R 3.0.2. (R Foundation for Statistical Computing,
Vienna, Austria). A 2-tailed p value of0.05 was considered
statistically significant.
Results
Characteristics of the participants, stratified by the pres-
ence of delirium, are presented in Table 1. Table 2 sum-
marizes differences between patients in the TAVI and
SAVR groups. TAVI was performed in 46% of the patients.
General anesthesia was used in 48% of patients who un-
derwent TAVI and in all patients who underwent SAVR
(p 0.001). The mean length of stay in patients who un-
derwent TAVI was 8.8 days (SD 6.0) versus 7.9 days (SD
4.7) after SAVR. The relatively long length of stay after
TAVI was partly related to the general condition of the
patients and to the risk of postoperative AV blockage and
pacemaker requirement up to a week after CoreValve
implantation.
New cases of PD occurred at least once in 56% of
octogenarians during the 5-day study period. Of patients in
the TAVI group, 44% developed PD compared to 66% of
patients in the SAVR group (p ¼ 0.01). Of the TAVI
patients developing PD, 54% received general anesthesia
(p ¼ 0.40). The logistic regression model revealed that PD
was associated with cognitive function and treatment type
Table 3
Logistic regression model of risk factors for delirium in octogenarian aortic stenosis patients (n¼135)
Unadjusted Adjusted
Odds ratio 95% CI P-value Odds ratio 95% CI P-value
Gender 0.26 0.60
Male (ref.) 1 e 1 e
Female 0.67 0.34e1.34 0.82 0.38e1.76
ADL score 0.82 0.63e1.05 0.12 0.81 0.60e1.07 0.14
Atrial fibrillation 1.58 0.74e3.46 0.24 1.84 0.79e4.49
Comorbidity score 1.02 0.76e1.36 0.92 1.08 0.78e1.51 0.64
Frailty 0.54 0.59
Robust (ref.) 1 e 1 e
Prefrail/frail 0.80 0.38e1.64 0.80 0.35e1.81
MMS score 0.91 0.79e1.02 0.11 0.85 0.73e0.98 0.03
Postoperative use of opioids 2.32 0.94-5.99 0.07 1.61 0.52e5.17 0.41
Postoperative use of anxiolytics 0.97 0.47-2.03 0.94 1.09 0.49e2.45 0.83
Treatment TAVI 0.43 0.21e0.85 0.02 0.34 0.14e0.82 0.02
ADL ¼ Activities of Daily Living; MMSE ¼ Mini Mental Status Examination; SOF ¼ Study of Osteoporotic Fractures; TAVI ¼ transcatheter aortic valve
implantation.
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(Table 3). The average number of days with PD for patients
observed for all 5 days did not differ between patients
treated with TAVI and SAVR (1.1 vs 1.5, p ¼ 0.20), but the
course of PD did. Figure 2 shows that patients in the TAVI
group, who did not develop PD during the first post-
operative day, usually did not experience PD in the suc-
ceeding 4 days. Seventy-four percent of patients in the
TAVI group experienced PD on the first day, whereas only
46% of patients in the SAVR group did (Figure 2). Figure 3
shows PD-free survival for the treatment groups. The groups
differed with respect to time to the first onset of PD (exact
log-rank test for interval-censored data; p ¼ 0.03).
Discussion
To the best of our knowledge, this is the first study to
systematically explore factors associated with PD during 5
consecutive postoperative days in octogenarian patients
needing TAVI or SAVR. The incidence of PD was signif-
icantly higher in octogenarians with reduced cognitive
function and in those treated with SAVR. Differences in PD
onset were also found between treatment groups.
The incidence of PD after cardiac surgery is high.4,14 In
general, patients accepted for TAVI have a higher surgical
risk than patients receiving SAVR.2,3 In our sample, patients
who underwent TAVI were older, had lower MMSE scores,
greater comorbidity scores, higher logistic EuroScore, and
were classified in more-severe ASA categories. Despite this,
44% of patients scheduled for TAVI experienced PD
compared to 66% of patients in the SAVR group, suggesting
that TAVI is better tolerated with regards to PD.
Cognitive and ADL impairment are well-established risk
factors for PD in cardiac and noncardiac patients,4,19 and our
analyses provide additional evidence linking lower cognitive
function to higher risk for PD. Although entry of ADL
function in the regression model did not reach significance, a
ceiling effect may have been present and our results must be
interpreted with caution. The relatively good cognitive func-
tion of our cohort is similar to other cardiac populations in
which PD has been studied.6,13 Yet, it must be taken into
account that in recent years, the accuracy of MMSE in diag-
nosing mild cognitive impairment has been questioned.28
In our study, co-morbidity, ASA score, and EuroScore
were not associated with PD, according to univariate and
multivariate analysis. However, because of 90% of our pa-
tients had 1 or more co-morbidities, we had insufficient
power to detect a difference between patients lacking and
those having some co-morbidities. General anesthesia,
sternotomy, and extracorporeal circulation are procedures
related to SAVR that might put excessive burden on octo-
genarian patients. Sedation might moderate the adverse ef-
fects of general anesthesia that could lead to PD.10
Univariate analysis showed a relation between PD and
anesthesia type (general vs sedation). However, when con-
trolling for other variables, this relation disappeared.
Stress and inflammation responses are associated with
PD.4 Lower activation of stress hormones might be present
in patients who underwent TAVI as less tissue damage and
inflammation is associated with the procedure. The SAVR
procedure involved full sternotomy. Hence, we were unable
to determine whether less-invasive procedures such as
ministernotomy or minithoracotomy would influence the
incidence or onset of PD in patients who underwent SAVR.
It is still unknown if the new sutureless valve prostheses
designed for fast deployment in the aortic root might reduce
postoperative complications such as PD.
Appropriate pain management and mobilization can
prevent PD after surgery; still, opioids have been associated
with the onset of PD.19 We did not find any statistical as-
sociation between opioids and PD after adjusting for other
risk factors. The postoperative use of anxiolytics was also
entered in the regression model without reaching statistically
significant values. Yet, the confidence intervals of these 2
variables are wide and results should be interpreted with
caution. Our data revealed that patients who underwent
TAVI received less amounts of postoperative opioids and
paracetamol and earlier mobilization. It can be speculated
that the gentler TAVI leads to lower postoperative pain and
Figure 3. KaplaneMeier survival curves showing time to onset of PD for TAVI and SAVR. Patients who died or became critically ill are excluded. Patients
with data missing for administrative reasons or who were discharged were censored for the remaining duration of their hospital stay (n ¼ 130).
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easier mobilization. Postoperative routines in our hospital
encourage patients to leave bed the same day TAVI is
performed, and by the first postoperative day, patients who
underwent TAVI are ambulating the cardiology ward.
Mobilization after SAVR starts the day after surgery but is
restricted by the use of electrocardiography devices, pul-
monary tubes, temporal pacemaker, urine catheters, and
intravenous lines during the first 48 hours, supporting evi-
dence that physical restraints might precipitate PD.4
Delirium and frailty have been proposed to be different
representations of the inability to compensate for stressors.29
Additionally, the relation between frailty and delirium has
been questioned.29 Using the SOF Frailty Index, this study
is one of the first to assess preoperative frailty as a risk
factor for PD. The logistic regression analysis showed that
frailty plays a limited role as a predictor of PD in octoge-
narian patients with AS.
PD developed at different times in the 2 groups of pa-
tients. During the first postoperative day, PD occurred in
several patients regardless of the treatment (Figure 2). Dif-
ferences emerged from the second postoperative day. Our
data indicate that patients in the TAVI group who did not
develop PD during the first postoperative day were unlikely
to develop PD thereafter. In patients treated with SAVR, the
onset of PD could occur at any time during the 5 days of
assessment (Figure 2).
The strengths of this study lie in its prospective design
and use of valid and reliable instruments. PD was assessed
by trained research assistants who performed the assessments
for 5 days, including weekends. Additionally, our hospital is
1 of 5 centers in Norway performing TAVI, and in western
Norway all TAVI and SAVR procedures are performed in
our hospital setting. This allowed us to study a representative
group of octogenarian patients with AS from this part of the
country. Few patients (6%) refused to participate, and <2%
were not identified before treatment. Thus, these factors
argue for generalizability. The high incidence of PD (56%)
in our study can be explained by the robust method used to
evaluate PD, which included a highly recommended tool
used to identify delirium,18 bedside contact with eligible
patients, review of medical, nursing, and physiotherapist
reports written 24 hours before assessment with CAM, and
direct contact with nurses during the morning shift.
Limitations of the study include a nonrandomized treat-
ment location. Yet, as pointed out in the PARTNER trial,3 a
randomized study to compare treatment modalities was not
possible because TAVI and SAVRwere used to treat distinctly
different patient populations. Body Mass Index, sensory
impairment, ASA, and EuroScore are important variables that
could not be included in the logistic regression because of our
modest sample size. This limitation warrants bigger studies of
octogenarians patients with AS who underwent AVR. The
lack of preoperative and postoperative information regarding
brain pathology is also a limitation. However, important in-
formation about brain reserve and vulnerability for delirium
comes from assessment of patients’ preoperative cognitive
function using the MMSE. Nevertheless, it is possible that
other cognitive measurements should have complemented our
data. Preoperative organic cerebral disease, precerebral
vascular lesions, and thoracic aortic atherosclerosis may all be
important risk factors for postoperative cerebral dysfunction.
However, as cerebral computed tomography or magnetic
resonance imaging or imaging of the thoracic aorta or pre-
cerebral vascularity was not part of the study protocol, we
were unable to conduct any further evaluation of organic risk
factors related to general atherosclerosis or embolic risk. The
relatively good cognitive and ADL function of our patients
might indicate the presence of patient selection bias before
referral to our hospital. This can limit the generalizability of
our results to populations living in areas where selection
criteria for AS intervention are less strict. Additionally, our
study did not evaluate the severity of PD.
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Delirium as a Predictor of Physical and Cognitive Function in
Individuals Aged 80 and Older After Transcatheter Aortic Valve
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OBJECTIVES: To determine how development of delir-
ium after surgical aortic valve replacement (SAVR) or
transcatheter aortic valve implantation (TAVI) could pre-
dict activity of daily living (ADL) and instrumental ADLs
(IADL) disability, cognitive function, and self-reported
health in individuals aged 80 and older.
DESIGN: Prospective cohort study.
SETTING: Tertiary university hospital.
PARTICIPANTS: Individuals aged 80 and older undergo-
ing elective SAVR or TAVI (N = 136).
MEASUREMENTS: Delirium was assessed for 5 days
using the Confusion Assessment Method. The Barthel
Index, Nottingham Extended ADL Scale, and SF-12 were
used to determine ADL and IADL ability and self-reported
health at baseline and 1- and 6-month follow-up. Cogni-
tion was assessed using the Mini-Mental State Examina-
tion at baseline and 6-month follow-up.
RESULTS: Participants had lower IADL scores 1 month
after SAVR than at baseline (baseline 58, 1 month: delirium
42, no delirium 50, P ≤ .02), but scores had returned to
baseline levels at 6 months. The Medical Outcomes Study
12-item Short-Form Health Survey (SF-12) Physical Compo-
nent Summary (PCS) score was higher at 6-month follow-up
(48) than at baseline (39), especially in participants who did
not develop delirium (P < .001). No differences in other
outcomes were found. Regression models suggest that delir-
ium may help predict IADL disability 1 month after baseline
(P ≤ .07) but does not predict large differences in ADL dis-
ability, cognitive function, or SF-12-scores. Individuals who
underwent TAVI and developed delirium had lower ADL
(baseline 19, 1-month 16, P < .001) and IADL (baseline 49,
1-month 40, P = .003) scores at 1-month follow-up. SF-12
PCS score (baseline 30) increased from baseline to 1- (35,
P = .04) and 6- (35, P = .02) month follow-up in individu-
als who underwent TAVI and did not develop delirium.
Delirium after TAVI predicted greater ADL and IADL dis-
ability at 1-month but not at 6-month follow-up.
CONCLUSION: Individuals who develop delirium after
SAVR and TAVI have poorer short-term IADL function
but do not seem to have long-term reductions in physical,
mental, or self-reported health. J Am Geriatr Soc 2016.
Key words: aortic stenosis; delirium; self-reported
health status; TAVI
A high incidence of delirium occurs in elderly adultsundergoing cardiac surgery.1–3 The prevalence of aor-
tic stenosis is greater in elderly adults than in the general
population.4 Even though symptomatic aortic stenosis has
high mortality when untreated,5 the risk of performing
surgical aortic valve replacement (SAVR) might be too
high in frail elderly adults with several comorbidities.6
Transcatheter aortic valve implantation (TAVI) is an
option for individuals for whom SAVR is unsuitable.6,7
Functional and cognitive decline have been reported in
individuals experiencing delirium after hip fracture8 and car-
diac surgery.9–11 For aortic stenosis, current knowledge about
delirium is mostly based on individuals treated with SAVR
and those younger than 80.9,11 Individuals aged 80 and older
undergoing TAVI have a lower incidence of delirium than
those undergoing SAVR,12 although it is unclear whether
delirium after the less-invasive TAVI leads to equally adverse
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effects in terms of activities of daily living (ADLs), instrumen-
tal activities of daily living (IADLs), and cognitive function
when assessed 1 and 6 months after treatment.
Perception of health is important when longevity is
not a dominant priority.13 Measurement of self-reported
health status in elderly populations has been suggested as
being important,14 and quality of life after TAVI has been
studied to some extent,15,16 but little is known about how
delirium affects the self-reported health of individuals aged
80 and older after aortic valve implantation. The aim of
this study was therefore to determine how delirium could
predict ADL and IADL function, cognitive function, and
self-reported health status in individuals aged 80 and older
1 and 6 months after treatment with SAVR or TAVI.
METHODS
This was a prospective cohort study of individuals consec-
utively undergoing elective TAVI or SAVR in a tertiary
hospital in western Norway.
Study population
Individuals were recruited into the larger Delirium in
Octogenarians Undergoing Cardiac Surgery or Intervention
(CARDELIR) study.12 Inclusion criteria were aged 80 and
older, severe aortic stenosis, and elective treatment with
TAVI or SAVR. Exclusion criteria were inability to speak
and understand Norwegian or declined consent to partici-
pate. According to guidelines on management of valvular
heart diseases, severe aortic stenosis is defined as aortic
valve area of less than 0.6 cm2/m2, mean gradient of
greater than 40 mmHg, and maximum jet velocity of
greater than 4.0 m/s.17 A specialist heart team comprising
cardiothoracic surgeons and invasive cardiologists identified
individuals who were unsuitable for SAVR. Previous coro-
nary artery bypass graft, severe respiratory insufficiency,
comorbidities that could compromise recovery, calcified
ascending aorta, and prior thoracic radiotherapy were the
main reasons for being ineligible for treatment with SAVR.
From February 2011 until August 2013, 162 individuals
aged 80 and older were treated with SAVR or TAVI. Of
these, 15 failed to fulfill the inclusion criteria. The remaining
147 received study information, and 144 of these agreed to
participate, although data analyzed for this study included
those from only 136 individuals, because one withdrew con-
sent before treatment, and delirium was not established in
seven because they were nonresponsive or had died. An indi-
vidual was classified as having experienced delirium if delir-
ium was identified on at least 1 of the 5 postoperative days.
Individuals who were not tested for delirium because of
administrative or other reasons were classified according to
delirium status for the days that they were tested.
Measurements
Delirium
The Confusion Assessment Method (CAM), which identifies
delirium based on acute onset and fluctuating course, inatten-
tion, disorganized thinking, and altered level of conscious-
ness, was used to assess delirium.18 Delirium is diagnosed
when the first two features and the third or the fourth are pre-
sent.18 The psychometric properties of the CAM are good.19
Physical Function
Activities of Daily Living
The Barthel Index, which evaluates self-care abilities in
feeding, bathing, grooming, dressing, bowel, bladder, toilet
use, transferring, walking, and using stairs, was used as
one measure of activity level. The maximum score is 20,
and a score of at least 19 indicates functional indepen-
dence.20 When administered in an interview, the Barthel
Index has sufficient psychometric properties to provide a
valid measure ADLs.21
Instrumental Activities of Daily Living
The Nottingham Extended Activities of Daily Living Scale
uses 22 items to evaluate an individual’s ability to perform
complex levels of functioning, such as cooking, household
management, and use of public transportation. Each item
is scored from 0 to 3, and the items are summed, with 66
being the highest score. Higher scores indicate greater
levels of independence.22 This index is reliable and valid.23
Cognitive Function
Cognitive function was assessed using the Mini-Mental
State Examination (MMSE),24 which has a range of 0–30
points, with 30 indicating the best cognition. In the Nor-
wegian version, a score of 27 or less indicates poor cogni-
tive function. The MMSE is a valid instrument for
assessing global cognitive function.24
Self-Reported Health Status
Medical Outcomes Study 12-Item Short-Form Health
Survey
The Medical Outcomes Study 12-Item Short-Form Health
Survey (SF-12) was used to measure subjective general
health.25 It is a generic, self-assessed health index based on
12 items and is combined into two summary scores: the
Physical Component Summary (PCS) and the Mental Com-
ponent Summary (MCS). Scores range from 0 to 100, with
higher scores indicating better self-reported health status.
The psychometric properties of the SF-12 are good.25
Other Study Variables
Comorbidity
The Charlson Comorbidity Index, which predicts mortality
in individuals with comorbid disorders, was used to quan-
tify comorbidities.26 It has been shown to have good psy-
chometric properties.26,27
Cardiac Operative Risk
The Logistic European System for Cardiac Operative Risk
Evaluation I (Logistic EuroSCORE I), which uses a scoring
system that calculates operative mortality for individuals
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undergoing cardiac surgery, was used to evaluate mortality
risk.28 The Logistic EuroSCORE I takes into consideration
17 risk variables that predict mortality. Higher scores indi-
cate greater operative mortality risk.29
The selection of explanatory variables included in the
prediction models for the present study was based on pre-
vious research exploring the consequences of delirium after
cardiac surgery,9,11,30,31 taking into account clinical expe-
rience and the limited sample size.
Data Collection
Preoperative Data and Postoperative Assessment of
Delirium
A detailed description of preoperative data collection and
assessment of delirium was presented in a previous arti-
cle.12 Briefly, the day before treatment, ADL and cognitive
function were evaluated in individuals fulfilling the inclu-
sion criteria. A self-report form containing IADL and
SF-12 questionnaires was given to participants at the end
of the inclusion process and collected before surgery.
Demographic and clinical data were gathered from medical
records or in an interview, as appropriate.
The presence of delirium was measured daily, includ-
ing weekends, at approximately noon from Postoperative
Day 1–5. Research nurses trained in CAM performed clini-
cal assessments at participants’ bedsides. Medical, nursing,
and physiotherapist reports from the previous 24 hours
and meetings with health professionals in charge of the
participants were taken into consideration when scoring
the CAM.
One- and 6-Month Assessments
Follow-up visits were scheduled at the hospital 1 and
6 months after treatment. Information about ADL func-
tion was collected at this time, and self-report forms con-
taining IADL and SF-12 questionnaires were provided. If a
participant was unable to attend a follow-up visit, and a
new appointment could not be scheduled within a window
of 2 weeks, telephone contact was attempted. Information
required for the Barthel Index was collected over the tele-
phone, and then self-report forms containing IADL and
SF-12 questionnaires were mailed for completion at home.
The MMSE was administered after 6 months in partici-
pants attending follow-up visits.
Data Analyses
Data are presented as counts and percentages or means
and standard deviations or confidence intervals. Longitudi-
nal linear models were fitted separately, with time, delir-
ium, and the interaction between time and delirium as
explanatory factors to estimate mean ADL, IADL, MMSE,
SF-12 PCS, and SF-12 MCS scores at baseline and 1- and
6-month follow-up. To estimate how delirium could
improve predictions over baseline scores alone or baseline
scores and other risk or comorbidity factors, linear longi-
tudinal models for the scores were fitted at 1- and 6-month
follow-up using baseline score as an explanatory variable
for the unadjusted analysis and baseline score, sex,
Charlson Comorbidity Index, and logistic EuroSCORE I
as explanatory variables for the adjusted analysis.
All longitudinal models were fitted separately for
each treatment (SAVR, TAVI) using generalized least
squares with an unstructured correlation matrix. P ≤ .05
was considered statistically significant. Reported P-values
were not adjusted for multiple comparisons. Data man-
agement and initial statistical analyses were conducted
using SPSS version 22.0 (IBM SPSS Statistics for Win-
dows, Armonk, NY) and R 3.1.1 (R Foundation for Sta-
tistical Computing, Vienna, Austria) was used for all
reported statistical analyses except those reported in
Table 1. The R package “nlme” was used for longitudi-
nal analyses.
Missing Data
Data were screened and checked for missing units (ques-
tionnaires) and loss of single items.32 Before data collec-
tion started, a coding system for missing data was
implemented (participant did not answer item, participant
withdrew from study, participant died). Participants with
incomplete baseline SF-12 units were more likely to be
male (P = .02). Otherwise, no differences were found at
baseline or follow-up in terms of sex, comorbidity, or mar-
ital or educational status between participants with com-
plete and incomplete units.
By the time data collection ended, 22 participants
were lost-to-follow-up, nine of whom had withdrawn
from the study (8 treated with SAVR) and 13 of whom
had died (8 treated with TAVI). Including participants
who were lost to follow-up, cognitive screening
6 months after treatment was not performed in 45
(31%). Twenty-two of these participants did not attend
6-month follow-up at the hospital. The majority of these
nonattendees were living more than 2 hours away from
the hospital; five said that the hospital was too far away
from their residence to attend the consultation, nine that
they were not well enough to travel, and four that they
were healthy and did not need further follow-up exami-
nation; three did not indicate their reason for not
attending the follow-up; and two could not be con-
tacted. Participants who did not attend their 6-month
follow-up visit did not differ from those attending in
terms of sex (P = .27), baseline comorbidities (P = .74),
or baseline MMSE score (P = .83).
Handling of Missing Data
Because it could not be assumed that data were missing
completely at random, a likelihood-based longitudinal
model, requiring only the much weaker missing at random
assumption, was used. Still, there could be informative
censoring that the model did not capture, with, for exam-
ple, participants showing greater improvements from base-
line being more likely to respond to the follow-up
questionnaire. A sensitivity analysis for the changes from
baseline was therefore performed in which all missing data
were replaced with participants’ baseline values and the
statistical analysis repeated. The results from the sensitivity
analysis can be seen in Figure S1.
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Ethical Considerations
This study was conducted in accordance with the Declara-
tion of Helsinki and approved by the Regional Committee
for Ethics in Medical Research in Norway (REK Vest
2010/2936–6). Special consideration was given to signs of
participant exhaustion during data collection. Whenever
these signs were present, data collection was stopped and
later resumed.
RESULTS
Characteristics of the Study Population
Clinical and sociodemographic characteristics of included
participants are presented in Table 1. Fifty-seven percent
of the participants were female, and TAVI was performed
in 46% of the study population. Participants in the TAVI
group were older (P < .001) and had more comorbidities
(P < .001), a higher Logistic EuroSCORE I (P < .001),
poorer IADL function (P < .001), lower MMSE scores
(P = .007), lower SF-12 PCS scores (P = .002), and lower
SF-12 MCS scores (P = .09).
Participants without delirium were not different from
those with delirium in terms of sex (P > .14), comorbidity
index (P > .20), or logistic EuroSCORE (P > .31), but par-
ticipants treated using SAVR developed delirium more
often than participants treated with TAVI (P = .01).
Postoperative Delirium
An earlier article12 presented the incidence of delirium in
the studied population. Delirium was identified in 66% of
participants in the SAVR group and 44% of those in the
TAVI group.12
ADLs–SAVR Group
ADL scores of participants treated with SAVR were simi-
lar to baseline scores at 1- and 6-month follow-up regard-
less of the presence of delirium (all P > .05) (Figure 1).
Delirium did not predict performance well when adjusted
for baseline or baseline and other risk factors (Table 2).
ADLs–TAVI Group
At 1-month follow-up, participants in the TAVI group
with delirium had much worse mean ADL scores than at
baseline. After 6 months, ADL scores for the TAVI group
with delirium had improved and were no longer statisti-
cally significantly different from baseline scores (P = .06).
The 1- and 6-month follow-up scores of participants
undergoing TAVI who did not develop delirium were simi-
lar to their baseline scores (Figure 1). The regression
models showed that delirium predicted performance well
at 1-month follow-up, even when baseline ADL function
was included as a linear predictor in the models (Table 2).
Table 1. Characteristics of Individuals Aged 80 and Older Undergoing Transcatheter Aortic Valve Implantation















Age, mean  SD 83.5  2.7 81.6  1.4 82.7  2.3 .01 84.7  2.8 84.9  2.8 .74
Female, n (%) 76 (56) 12 (48) 24 (50) .87 25 (71) 15 (54) .14
Married, n (%) 73 (54) 16 (64) 27 (56) .52 15 (43) 15 (54) .40
Activity of daily living function, mean  SD
(range 0–20)
18.9  1.5 19.5  1.0 18.9  1.5 .06 18.9  1.5 18.5  1.4 .28
Instrumental activity of daily living function,
mean  SD (range 0–66)
54.2  10.1 57.1  8.7 57.5  7.9 .87 52.4  10.9 48.6  11.1 .21
Mini-Mental State Examination score, mean  SD
(range 0–30)
27.2  2.9 27.9  2.2 27.8  2.8 .86 27.4  2.4 25.4  3.6 .01
Medical Outcomes Study 12-Item Short Form Survey score, mean  SD (range 0–100)
Physical Component Summary 33.9  10.6 38.4  8.8 36.2  10.4 .40 30.5  10.0 30.9  11.3 .88
Mental Component Summary 48.7  10.8 50.3  10.6 50.1  10.4 .94 47.0  8.3 47.1  14.1 .95
Charlson Comorbidity Index, mean  SD 2.1  1.2 1.8  1.0 1.8  0.9 .78 2.3  1.3 2.7  1.3 .20
Logistic European System for Cardiac Operative Risk
Evaluation I, mean  SDa
14.0  9.2 9.9  3.8 8.8  3.1 .31 19.4  1.0 19.8  11.6 .86
New York Heart Association class
I + II 47 (35) 13 (54) 24 (54) .98 6 (19) 4 (18) .96
III + IV 75 (55) 11 (46) 20 (45) .98 26 (81) 18 (81) .96
Left ventricular ejection fraction, % 56.6  10.2 57.2  12.0 57.3  9.4 .97 55.9  10.4 55.6  10.3 .89
Maximum aortic gradient, mmHg 79.5  23.9 86.2  26.7 82.1  23.8 .54 73.4  23.7 76.9  20.9 .54
Mean aortic gradient, mmHg 48.3  16.1 51.6  16.8 50.1  16.2 .72 45.6  16.0 45.9  15.2 .93
Aortic valve area, cm2/m2 0.4  0.2 0.4  0.1 0.4  0.2 .29 0.4  0.1 0.4  0.07 .40
American Society of Anesthesiologists classification, n (%)
3 114 (84) 25 (100) 46 (96) .30 23 (66) 20 (71) .63
4 22 (16) 0 (0) 2 (4) .30 12 (34) 8 (29) .63
SD = standard deviation.
aP-value based on log-transformed values.
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This analysis also showed that participants who developed
delirium had mean baseline-adjusted scores 3.1 points
lower (worse) than those who did not (P = .002). This
effect also persisted when adjusting for other risk and
comorbidity factors (sex, Charlson Comorbidity Index,
baseline logistic EuroSCORE I) (P = .001). At 6-month
follow-up, presence of delirium in the first 5 days after
surgery no longer predicted ADL performance.
IADLs–SAVR Group
IADL scores at 1-month follow-up were lower than at
baseline for participants who did not develop delirium
(P = .02) and even lower for those who did (P < .001).
There were no or minor differences from baseline at 6-
month follow-up (P = .50 for participants without delir-
ium, P = .05 for SAVR participants with delirium). The
Figure 1. Model-based estimated means for activities of daily living (ADLs; possible range of scores 0–20), instrumental activities
of daily living (IADLs; possible range of scores 0–66), Mini-Mental State Examination (MMSE; possible range of scores 0–30),
and Medical Outcomes Study 12-item Short Form Survey scores ((SF-12) possible range of scores 0–100) (with 95% confidence
intervals) at baseline and 1- and 6-month follow-up. Organized according to treatment (surgical aortic valve replacement
(SAVR), transcatheter aortic valve implantation (TAVI)) and presence or absence of delirium (circles and triangles, respectively)
(N = 136). The result of testing for change from baseline, based on longitudinal models, is shown as P-values at each time point.
See Table 2 for information on the number of observations used to estimate each outcome.
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regression models showed no predictive power of delirium
at 6 months but suggest a possible moderate to large effect
size at 1 month (not statistically significant) (Table 2).
IADLs–TAVI Group
At 1-month follow-up, IADL scores did not differ from
baseline in participants who did not develop delirium
(P = .60) but were lower than at baseline for those who
did (P = .003). There were no differences in scores from
baseline to 6-month follow-up independent of delirium
(without delirium, P = .60; with delirium, P = .40) (Fig-
ure 1). The regression models showed that, for participants
undergoing TAVI, delirium predicted performance well at
1-month follow-up, even after adjusting for baseline IADL
function. According to this analysis, participants who
developed delirium had mean baseline-adjusted scores that
were approximately 10 points lower (worse) than scores of
those who did not (P = .005). This was also the case when
adjusted for other risk and comorbidity factors (Table 2).
MMSE–SAVR Group
There were no differences in cognitive function between
baseline and 6-month follow-up in participants who did
and did not develop delirium (Figure 1). For participants
undergoing SAVR, the regression models showed no signif-
icant improvement in prediction when including delirium
as a predictor in the analysis (Table 2).
MMSE–TAVI Group
Although individuals undergoing TAVI who developed
delirium had lower overall scores than those who did
not (even at baseline), no differences in cognitive
function were found 6 months after treatment (Table 2).
Taking into account baseline MMSE score and other
risk factors, including information on the presence or
absence of delirium did not improve predictions
(Table 2).
SF-12 PCS–SAVR Group
There were minor, statistically nonsignificant changes in
SF-12 PCS score after 1 month. Participants who did
and did not develop delirium had a major increase in
scores at 6-month follow-up (P ≤ .007) (Figure 1). The
regression models found no improvements in prediction
when taking the presence of delirium into account,
except for a significant (P = .05) effect after 6 months
(Table 2).
SF-12 PCS–TAVI Group
At 1-month follow-up, only participants who did not
develop delirium had a statistically significant improve-
ment in self-reported physical health (P = .04). Six months
later, there were improvements in all participants (Fig-
ure 1). The regression models showed no improvement in
prediction when taking the presence of delirium into
account (Table 2).
SF-12 MCS–SAVR Group
There were no statistically significant differences on the
SF-12 MCS at 1- or 6-month follow-up (Figure 1). The
regression model revealed no improvement in prediction
when taking the presence of delirium into account
(Table 2).
Table 2. Effect of Experiencing Delirium on Physical and Cognitive Function and Self-Reported Health, Adjusted
for Baseline Values, at 1- and 6-Month Follow-Up, for Individuals Aged 80 and Older with Severe Aortic Stenosis
Assessment



















Activity of daily living function 67 0.3, .60 0.1, .90 0.0, >.99 0.3, .70 60 3.1, .002 1.5, .10 3.1, .001 1.6, .10
Instrumental activity of daily living
function
47 8.1, .07 1.8, .70 9.4, .06 3.0, .60 48 10.6, .004 3.0, .40 10.5, .005 2.3, .50
Mini-Mental State Examination 45 0.3, .70 0.6, .50 52 1.1, .40 1.4, .20
Medical Outcomes Study 12-Item Short Form Survey
Physical Component Summary 52 2.9, .20 4.1, .10 4.0, .10 4.9, .05 44 0.6, .80 0.9, .80 0.6, .80 1.1, .70
Mental Component Summary 52 5.1, .10 5.1, .10 6.3, .06 4.3, .20 44 4.0, .20 2.4, .40 3.6, .20 3.0, .30
aAdjusted for baseline score.
bAdjusted for sex and baseline score, Charlson Comorbidity Index, and Logistic European System for Cardiac Operative Risk Evaluation I.
cEstimated difference in mean score between an individual experiencing delirium and an individual not experiencing delirium based on a linear longitudinal
model with the mean score of the individual experiencing delirium modeled as a linear function of experiencing delirium and baseline value/baseline value
and other risk factors.
*Number of patients included in the models, i.e., with at least one measurement (baseline, 1 month and/or 6 month).
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SF-12 MCS–TAVI Group
No statistically significant changes were found in partici-
pants who did or did not develop delirium at 1- or 6-
month follow-up (Figure 1). For participants undergoing
TAVI, there was no effect of delirium at 1- or at 6-month
follow-up (Table 2).
Sensitivity Analysis
The results from the sensitivity analysis showed only minor
changes in the estimated effects, so the findings seem
robust. All changes from baseline with P ≤ .04 (in Fig-
ure 1) remained statistically significant. The results from
the sensitivity analysis are presented in Figure S1. This
supplement is organized like Figure 1, but all estimates
and P-values are based on the sensitivity analysis model
described.
DISCUSSION
To the best of the knowledge of the authors, this is the
first study to examine delirium as a predictor of ADL,
IADL, and cognitive function and self-reported health in
individuals aged 80 and older after TAVI. This work
demonstrates how delirium affects individuals aged 80 and
older after SAVR or TAVI, the latter being a less-invasive
treatment.
Previous studies found an association between delir-
ium and functional decline after hip fracture8 and cardiac
surgery.9,11 It has been suggested that functional impair-
ment is an important end point after cardiac surgery in
older adults.33,34 The current study shows that, at 1-month
follow-up, participants who underwent TAVI and devel-
oped delirium had a major decrease in ADL scores. This
effect persisted after adjusting for baseline ADL score and
other risk factors. The same level of decrease was not pre-
sent in individuals aged 80 and older undergoing the
more-invasive SAVR. One could argue that individuals
aged 80 and older scheduled for TAVI are more vulnerable
than those undergoing SAVR. ADL scores in participants
undergoing TAVI and not developing delirium remained
constant from baseline to follow-up.
IADL function has been linked to cognition.35 In the
current study, participants with delirium scored lower on
the IADL scale at 1-month follow-up than those without
delirium: 16 points for participants undergoing SAVR and
9 points for participants undergoing TAVI. Diminished
IADL performance might be expected, especially after
SAVR, which requires full sternotomy, aortic cross-clamp-
ing, and extracorporeal bypass circulation. Furthermore,
electrocardiography devices, temporal pacemakers, and
catheters limit mobility during the immediate postoperative
period. After 6 months, the IADL scores of individuals
who underwent TAVI and SAVR had increased and did
not significantly differ from baseline.
Important differences in cognitive function were iden-
tified. MMSE scores at baseline and 6-month follow-up of
individuals who underwent TAVI and developed delirium
were approximately 2 points lower than scores of partici-
pants undergoing TAVI who did not develop delirium,
although the cognitive changes from baseline to 6-month
follow-up in all participants treated with TAVI were not
significant. No differences were observed in MMSE scores
of participants who underwent SAVR, regardless of devel-
opment of delirium. Even though diminished cognitive
function has been reported 6 months after hip fracture in
individuals with delirium,36 and delirium has been shown
to be associated with persistent cognitive impairment and
prolonged recovery up to 1 year after cardiac surgery,31 a
decrease in cognitive scores 6 months after SAVR or TAVI
was not observed. These encouraging results compare
favorably with findings from other studies30 and provide
further knowledge in the area of delirium by including
individuals undergoing cardiac surgery aged 80 and older
treated with a novel aortic valve therapy. The study mea-
sured cognitive function only at baseline and 6-month fol-
low-up, and it was not possible to explore possible
fluctuations that could have occurred during the intermedi-
ate postoperative period. It also cannot be determined
whether some participants developed cognitive impairment
after 6 months.
The SF-12 has been used to measure self-reported
health status after SAVR and TAVI.37–39 To the authors’
knowledge, the self-reported health of individuals aged 80
and older undergoing TAVI who develop delirium has not
been established. The PCS score of individuals who under-
went SAVR and developed delirium was lower (nonsignifi-
cantly) at 1-month follow-up than at baseline but
improved significantly at 6 months. The scores of individu-
als who underwent SAVR and did not develop delirium
remained constant at 1-month follow-up and improved
greatly after 6 months, supporting observations from the
Placement of AoRTic TraNscathetER Valve Trial.39 In the
current study, participants treated with TAVI had the low-
est PCS scores at baseline. Differences in scores between
the TAVI and SAVR groups became more accentuated
6 months after treatment, suggesting that individuals who
underwent TAVI were frail at baseline and remained frail
after treatment.
MCS scores of the SAVR and TAVI groups had a dif-
ferent pattern than others have reported.37,39 There was
no statistically significant difference in these scores from
baseline to 1- and 6-month follow-up. The utility of the
SF-12 for detecting changes over time in individuals with
heart failure has been questioned.40 Similarly, the SF-12
MCS may not be sufficiently sensitive to detect changes in
delirium. It is also possible that participants in the SAVR
group had higher expectations for the procedure than the
frailer group that underwent TAVI and developed delir-
ium. Nevertheless, it is surprising that cognitive, ADL, and
IADL function were well preserved in the SAVR cohort,
because these participants did not receive as much screen-
ing as those in the TAVI group regarding general
atherosclerosis and aortic calcification. This indicates that
the selection and quality of surgery and perioperative
treatment of participants were good, because participants
who underwent TAVI were older and had a higher Euro-
SCORE and more comorbidities. It also shows that SAVR
may be performed safely in individuals aged 80 and older
with reasonably good physical and mental health. With
new technology (widespread use of intraoperative, epiaor-
tic ultrasound to detect aortic atheroma and thereby avoid
cerebral embolization; recently developed rapid
JAGS 2016 DELIRIUM IN OCTOGENARIANS AFTER TAVI OR SAVR 7
deployment aortic valve prostheses to reduce extracorpo-
real bypass circulation time in elderly adults undergoing
open surgery for aortic stenosis), SAVR may potentially be
performed with even less risk of cerebral complica-
tions.41,42
This study has several strengths, including its
prospective design with consecutive inclusion of individu-
als and its use of valid and reliable instruments. Further-
more, the study hospital performs all TAVI and SAVR
in western Norway, allowing the inclusion of a represen-
tative group of individuals aged 80 and older with sev-
ere aortic stenosis from the entire region. The fact that
the participants were more homogeneous in terms of
age, diagnosis, and treatment received than in other
studies9,11,30,31 can explain the high incidence of delir-
ium in the current study. Screening with CAM was per-
formed in a thorough manner at bedside for 5 days
postoperatively, starting on the first postoperative day.
Participants were also assessed on weekends and holi-
days. Meetings with health professionals in contact with
participants and close examination of their reports were
performed before the CAM was scored.
A limitation of the study is that it was not designed
as a randomized controlled trial. Randomization to com-
pare treatment modalities was not possible, because
TAVI and SAVR are used to treat distinctly different
target groups.6 Because of this, the results were analyzed
stratified according to treatment. Another limitation was
the modest size of the studied cohort. The results war-
rant future studies with larger samples. There was also
the risk of type 1 errors due to use of multiple testing.
The high ADL, IADL, and cognitive functioning of the
cohort may limit the applicability of the results to other
populations and might indicate that subject selection bias
was present before participants were referred to the uni-
versity hospital. It is also a limitation that cognitive
function at 6-month follow-up was not measured in the
22 participants who did not attend their consultation,
but the consequences of missing MMSE data at
6 months were investigated in a sensitivity analysis and
showed only minor changes in the estimated effects.
Other tools could have been added to complement the
cognitive evaluation done with the MMSE.43 Six months
may be considered a short follow-up period for evaluat-
ing the long-term consequences of delirium. This war-
rants further study with longer follow-up.
In conclusion, delirium is an important predictor of
lower ADL and IADL function 1 month after invasive
treatment for aortic stenosis, even when gentler tech-
niques such as TAVI are used. Lower ADL and IADL
scores at 1-month follow-up (Figure 1) in individuals
aged 80 and older with postoperative delirium address
the importance of prevention and recognition of the con-
dition. This is probably even more relevant in a popula-
tion in which functional ability is perhaps more
appealing than longevity. Close monitoring of individuals
at risk of developing delirium, even after less invasive
aortic valve therapy, is therefore recommend. Future
studies should focus on the effect of delirium on adverse
events demanding acute readmission to hospital and
nursing home placement in individuals aged 80 and
older after SAVR or TAVI.
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in estimated effects: activities of daily living (ADLs; possi-
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